A	O
functional	O
T-cell	B-protein
receptor	I-protein
signaling	O
pathway	O
is	O
required	O
for	O
p95vav	B-protein
activity	O
.	O

Stimulation	O
of	O
the	O
T-cell	B-protein
antigen	I-protein
receptor	I-protein
(	O
TCR	B-protein
)	O
induces	O
activation	O
of	O
multiple	O
tyrosine	B-protein
kinases	I-protein
,	O
resulting	O
in	O
phosphorylation	O
of	O
numerous	O
intracellular	O
substrates	O
.	O

One	O
substrate	O
is	O
p95vav	B-protein
,	O
which	O
is	O
expressed	O
exclusively	O
in	O
hematopoietic	B-cell_type
and	I-cell_type
trophoblast	I-cell_type
cells	I-cell_type
.	O

It	O
contains	O
a	O
number	O
of	O
structural	B-protein
motifs	I-protein
,	O
including	O
Src	B-protein
homology	I-protein
2	I-protein
,	I-protein
Src	I-protein
homology	I-protein
3	I-protein
,	I-protein
and	I-protein
pleckstrin	I-protein
homology	I-protein
domains	I-protein
and	O
a	O
putative	B-protein
guanine	I-protein
nucleotide	I-protein
exchange	I-protein
domain	I-protein
.	O

The	O
role	O
of	O
p95vav	B-protein
in	O
TCR	B-protein
-mediated	O
signaling	O
processes	O
is	O
unclear	O
.	O

Here	O
,	O
we	O
show	O
that	O
overexpression	O
of	O
p95vav	B-protein
alone	O
in	O
Jurkat	O
T	B-cell_type
cells	I-cell_type
leads	O
to	O
activation	O
of	O
the	O
nuclear	B-protein
factors	I-protein
,	O
including	O
NFAT	B-protein
,	O
involved	O
in	O
interleukin-2	B-protein
expression	O
.	O

Furthermore	O
,	O
p95vav	B-protein
synergizes	O
with	O
TCR	B-protein
stimulation	O
in	O
inducing	O
NFAT-	O
and	O
interleukin-2-dependent	O
transcription	O
.	O

In	O
contrast	O
,	O
NFAT	B-protein
activation	O
by	O
a	O
G-protein-coupled	B-protein
receptor	I-protein
is	O
not	O
modulated	O
by	O
p95vav	B-protein
overexpression	O
,	O
suggesting	O
that	O
the	O
effect	O
is	O
specific	O
to	O
the	O
TCR	B-protein
signaling	O
pathways	O
.	O

Although	O
removal	O
of	O
the	O
first	B-protein
67	I-protein
amino	I-protein
acids	I-protein
of	O
p95vav	B-protein
activates	O
its	O
transforming	O
potential	O
in	O
NIH	B-cell_line
3T3	I-cell_line
cells	I-cell_line
,	O
this	O
region	O
appears	O
to	O
be	O
required	O
for	O
its	O
function	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

We	O
further	O
demonstrate	O
that	O
the	O
p95vav	B-protein
-induced	O
NFAT	B-protein
activation	O
is	O
not	O
mimicked	O
by	O
Ras	B-protein
activation	O
,	O
though	O
its	O
function	O
is	O
dependent	O
upon	O
Ras	B-protein
and	O
Raf	B-protein
.	O

Furthermore	O
,	O
the	O
activating	O
function	O
of	O
p95vav	B-protein
is	O
blocked	O
by	O
FK506	O
,	O
suggesting	O
that	O
its	O
activity	O
also	O
depends	O
on	O
calcineurin	B-protein
.	O

To	O
further	O
dissect	O
p95vav	B-protein
involvement	O
in	O
TCR	B-protein
signaling	O
,	O
we	O
analyzed	O
various	O
Jurkat	B-cell_line
mutants	I-cell_line
deficient	O
in	O
TCR	B-protein
signaling	O
function	O
or	O
TCR	B-protein
expression	O
and	O
showed	O
that	O
an	O
intact	O
TCR	B-protein
signaling	O
pathway	O
is	O
required	O
for	O
p95vav	B-protein
to	O
function	O
.	O

However	O
,	O
overexpression	O
of	O
p95vav	B-protein
does	O
not	O
appear	O
to	O
influence	O
TCR	B-protein
-induced	O
protein	O
tyrosine	O
phosphorylation	O
or	O
increases	O
in	O
cytoplasmic	O
free	O
calcium	O
.	O

Taken	O
together	O
,	O
our	O
data	O
suggest	O
that	O
p95vav	B-protein
plays	O
an	O
important	O
role	O
at	O
an	O
yet	O
unidentified	O
proximal	O
position	O
in	O
the	O
TCR	B-protein
signaling	O
cascade	O
.	O

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BroLoGY	NULL
,	NULL
Aug.	NULL
1995	NULL
,	NULL
p.	NULL
4337-4346	NULL
0270-7306/95/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
1995	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

15	NULL
,	NULL
No	NULL
.	NULL

8	NULL
A	NULL
Functional	NULL
T-Cell	NULL
Receptor	NULL
Signaling	NULL
Pathway	NULL
Is	NULL
Required	NULL
for	NULL
p95	NULL
``	NULL
°	NULL
``	NULL
Activity	NULL
JUN	NULL
WU	NULL
,	NULL
``	NULL
SHULAMIT	NULL
KATZAV	NULL
,	NULL
``	NULL
anp	NULL
ARTHUR	NULL
WEISS*	NULL
>	NULL
**	NULL
Departments	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
``	NULL
and	NULL
Medicine®	NULL
and	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
``	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
California	NULL
94143	NULL
,	NULL
and	NULL
Lady	NULL
Davis	NULL
Institute	NULL
,	NULL
Jewish	NULL
General	NULL
Hospital	NULL
,	NULL
Montreal	NULL
,	NULL
Quebec	NULL
H3T	NULL
1E2	NULL
,	NULL
Canada	NULL
``	NULL
Received	NULL
15	NULL
March	NULL
1995/Returned	NULL
for	NULL
modification	NULL
28	NULL
April	NULL
1995/Accepted	NULL
12	NULL
May	NULL
1995	NULL
Stimulation	NULL
of	NULL
the	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
induces	NULL
activation	NULL
of	NULL
multiple	NULL
tyrosine	NULL
kinases	NULL
,	NULL
resulting	NULL
in	NULL
phosphorylation	NULL
of	NULL
numerous	NULL
intracellular	NULL
substrates	NULL
.	NULL

One	NULL
substrate	NULL
is	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
,	NULL
which	NULL
is	NULL
expressed	NULL
exclusively	NULL
in	NULL
hematopoietic	NULL
and	NULL
trophoblast	NULL
cells	NULL
.	NULL

It	NULL
contains	NULL
a	NULL
number	NULL
of	NULL
structural	NULL
motifs	NULL
,	NULL
including	NULL
Sre	NULL
homology	NULL
2	NULL
,	NULL
Src	NULL
homology	NULL
3	NULL
,	NULL
and	NULL
pleckstrin	NULL
homology	NULL
domains	NULL
and	NULL
a	NULL
putative	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
domain	NULL
.	NULL

The	NULL
role	NULL
of	NULL
p95	NULL
``	NULL
*	NULL
``	NULL
in	NULL
TCR-mediated	NULL
signaling	NULL
processes	NULL
is	NULL
unclear	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
show	NULL
that	NULL
overexpression	NULL
of	NULL
p95°	NULL
``	NULL
alone	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
leads	NULL
to	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
factors	NULL
,	NULL
including	NULL
NFAT	NULL
,	NULL
involved	NULL
in	NULL
interleukin-2	NULL
expression	NULL
.	NULL

Furthermore	NULL
,	NULL
p95	NULL
``	NULL
synergizes	NULL
with	NULL
TCR	NULL
stimulation	NULL
in	NULL
inducing	NULL
NFAT-	NULL
and	NULL
inter-leukin-2-dependent	NULL
transcription	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
NFAT	NULL
activation	NULL
by	NULL
a	NULL
G-protein-coupled	NULL
receptor	NULL
is	NULL
not	NULL
modulated	NULL
by	NULL
p95°	NULL
``	NULL
``	NULL
overexpression	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
effect	NULL
is	NULL
specific	NULL
to	NULL
the	NULL
TCR	NULL
signaling	NULL
pathways	NULL
.	NULL

Although	NULL
removal	NULL
of	NULL
the	NULL
first	NULL
67	NULL
amino	NULL
acids	NULL
of	NULL
p95	NULL
``	NULL
activates	NULL
its	NULL
transforming	NULL
potential	NULL
in	NULL
NIH	NULL
3T3	NULL
cells	NULL
,	NULL
this	NULL
region	NULL
appears	NULL
to	NULL
be	NULL
required	NULL
for	NULL
its	NULL
function	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

We	NULL
further	NULL
demonstrate	NULL
that	NULL
the	NULL
p95	NULL
``	NULL
``	NULL
-induced	NULL
NFAT	NULL
activation	NULL
is	NULL
not	NULL
mimicked	NULL
by	NULL
Ras	NULL
activation	NULL
,	NULL
though	NULL
its	NULL
function	NULL
is	NULL
dependent	NULL
upon	NULL
Ras	NULL
and	NULL
Raf	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
activating	NULL
function	NULL
of	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
is	NULL
blocked	NULL
by	NULL
FK506	NULL
,	NULL
suggesting	NULL
that	NULL
its	NULL
activity	NULL
also	NULL
depends	NULL
on	NULL
calcineurin	NULL
.	NULL

To	NULL
further	NULL
dissect	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
involvement	NULL
in	NULL
TCR	NULL
signaling	NULL
,	NULL
we	NULL
analyzed	NULL
various	NULL
Jurkat	NULL
mutants	NULL
deficient	NULL
in	NULL
TCR	NULL
signaling	NULL
function	NULL
or	NULL
TCR	NULL
expression	NULL
and	NULL
showed	NULL
that	NULL
an	NULL
intact	NULL
TCR	NULL
signaling	NULL
pathway	NULL
is	NULL
required	NULL
for	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
to	NULL
function	NULL
.	NULL

However	NULL
,	NULL
overexpression	NULL
of	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
influence	NULL
TCR-induced	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
or	NULL
increases	NULL
in	NULL
cytoplasmic	NULL
free	NULL
calcium	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
at	NULL
an	NULL
yet	NULL
unidentified	NULL
proximal	NULL
position	NULL
in	NULL
the	NULL
TCR	NULL
signaling	NULL
cascade	NULL
.	NULL

Engagement	NULL
of	NULL
the	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
by	NULL
a	NULL
pep-tide-bound	NULL
major	NULL
histocompatibility	NULL
complex	NULL
molecule	NULL
initiates	NULL
a	NULL
biochemical	NULL
cascade	NULL
involving	NULL
activation	NULL
of	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
(	NULL
PTKs	NULL
)	NULL
,	NULL
resulting	NULL
in	NULL
phosphorylation	NULL
of	NULL
multiple	NULL
intracellular	NULL
proteins	NULL
,	NULL
including	NULL
the	NULL
TCR	NULL
{	NULL
&	NULL
and	NULL
CD3	NULL
chains	NULL
,	NULL
ZAP-70	NULL
,	NULL
and	NULL
phospholipase	NULL
C-y1	NULL
(	NULL
PLC-y1	NULL
)	NULL
(	NULL
61	NULL
)	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
PLC-y1	NULL
induces	NULL
its	NULL
enzymatic	NULL
activity	NULL
(	NULL
45	NULL
)	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
generation	NULL
of	NULL
the	NULL
two	NULL
second	NULL
messen-gers	NULL
,	NULL
diacylglycerol	NULL
(	NULL
DAG	NULL
)	NULL
and	NULL
inositol	NULL
1,4,5-trisphosphate	NULL
,	NULL
which	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
rapid	NULL
and	NULL
sustained	NULL
intracellular	NULL
calcium	NULL
increase	NULL
and	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

These	NULL
early	NULL
biochemical	NULL
events	NULL
,	NULL
through	NULL
poorly	NULL
understood	NULL
processes	NULL
,	NULL
lead	NULL
to	NULL
a	NULL
variety	NULL
of	NULL
T-cell	NULL
functions	NULL
,	NULL
including	NULL
transcriptional	NULL
activation	NULL
of	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
gene	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
cellular	NULL
proteins	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
an	NULL
early	NULL
and	NULL
obligatory	NULL
step	NULL
in	NULL
TCR	NULL
signal	NULL
transduction	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
identification	NULL
and	NULL
understanding	NULL
the	NULL
function	NULL
of	NULL
these	NULL
molecules	NULL
is	NULL
of	NULL
considerable	NULL
interest	NULL
.	NULL

One	NULL
of	NULL
these	NULL
TCR-induced	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
is	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
(	NULL
6	NULL
,	NULL
42	NULL
)	NULL
,	NULL
the	NULL
product	NULL
of	NULL
a	NULL
proto-oncogene	NULL
expressed	NULL
exclusively	NULL
in	NULL
hematopoietic	NULL
and	NULL
trophoblast	NULL
cells	NULL
(	NULL
35	NULL
,	NULL
65	NULL
)	NULL
.	NULL

It	NULL
was	NULL
first	NULL
identified	NULL
as	NULL
a	NULL
result	NULL
of	NULL
its	NULL
malignant	NULL
activation	NULL
during	NULL
the	NULL
course	NULL
of	NULL
a	NULL
gene	NULL
transfer	NULL
assay	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Truncation	NULL
of	NULL
the	NULL
amino-terminal	NULL
leucine-rich	NULL
region	NULL
activates	NULL
its	NULL
transforming	NULL
potential	NULL
when	NULL
it	NULL
is	NULL
expressed	NULL
in	NULL
NIH	NULL
3T3	NULL
cells	NULL
(	NULL
11	NULL
,	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

p95	NULL
``	NULL
``	NULL
``	NULL
contains	NULL
a	NULL
putative	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
factor	NULL
(	NULL
GEF	NULL
)	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Box	NULL
0724	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
94143	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
415	NULL
)	NULL
476-1291	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
415	NULL
)	NULL
502-5081	NULL
.	NULL

4337	NULL
domain	NULL
for	NULL
small	NULL
GTPases	NULL
of	NULL
the	NULL
Rho/Rac	NULL
family	NULL
.	NULL

A	NULL
homolo-gous	NULL
domain	NULL
is	NULL
also	NULL
present	NULL
in	NULL
CDC24	NULL
and	NULL
Dbl	NULL
,	NULL
two	NULL
known	NULL
GEFs	NULL
for	NULL
Rho	NULL
and	NULL
Rac	NULL
proteins	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
also	NULL
contains	NULL
a	NULL
number	NULL
of	NULL
structural	NULL
motifs	NULL
shared	NULL
by	NULL
other	NULL
signaling	NULL
molecules	NULL
,	NULL
including	NULL
one	NULL
Sre	NULL
homology	NULL
2	NULL
(	NULL
SH2	NULL
)	NULL
domain	NULL
,	NULL
two	NULL
SH3	NULL
domains	NULL
,	NULL
a	NULL
pleckstrin	NULL
homology	NULL
domain	NULL
,	NULL
and	NULL
a	NULL
cysteine-rich	NULL
domain	NULL
(	NULL
39	NULL
,	NULL
44	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
show	NULL
that	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
becomes	NULL
tyrosine	NULL
phosphorylated	NULL
following	NULL
a	NULL
variety	NULL
of	NULL
stimuli	NULL
,	NULL
including	NULL
TCR	NULL
,	NULL
B-cell	NULL
antigen	NULL
receptor	NULL
,	NULL
and	NULL
IL-2	NULL
receptor	NULL
stimulation	NULL
(	NULL
5	NULL
,	NULL
6	NULL
,	NULL
16	NULL
,	NULL
42	NULL
)	NULL
.	NULL

When	NULL
p95	NULL
``	NULL
is	NULL
expressed	NULL
ectopically	NULL
in	NULL
fibroblasts	NULL
,	NULL
epidermal	NULL
or	NULL
platelet-derived	NULL
growth	NULL
factor	NULL
will	NULL
stimulate	NULL
its	NULL
rapid	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

Activation	NULL
of	NULL
epidermal	NULL
or	NULL
platelet-derived	NULL
growth	NULL
factor	NULL
receptors	NULL
also	NULL
results	NULL
in	NULL
association	NULL
of	NULL
the	NULL
receptors	NULL
with	NULL
p95¢	NULL
``	NULL
``	NULL
via	NULL
its	NULL
SH2	NULL
domain	NULL
(	NULL
6	NULL
,	NULL
42	NULL
)	NULL
.	NULL

Although	NULL
p95¢	NULL
``	NULL
``	NULL
so	NULL
far	NULL
has	NULL
not	NULL
been	NULL
found	NULL
to	NULL
associate	NULL
with	NULL
any	NULL
receptors	NULL
upon	NULL
ligand	NULL
stimulation	NULL
in	NULL
hematopoietic	NULL
cells	NULL
,	NULL
its	NULL
SH2	NULL
domain	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
a	NULL
number	NULL
of	NULL
signaling	NULL
molecules	NULL
,	NULL
including	NULL
ZAP-70	NULL
and	NULL
an	NULL
uncharacter-ized	NULL
tyrosine-phosphorylated	NULL
protein	NULL
,	NULL
Vap-1	NULL
(	NULL
5	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
p95¢	NULL
``	NULL
``	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
receptor-mediated	NULL
signaling	NULL
processes	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

TCR	NULL
activation	NULL
leads	NULL
to	NULL
cell	NULL
progression	NULL
from	NULL
resting	NULL
G	NULL
,	NULL
,	NULL
to	NULL
G	NULL
,	NULL
and	NULL
the	NULL
production	NULL
of	NULL
IL-2	NULL
.	NULL

IL-2	NULL
is	NULL
then	NULL
available	NULL
for	NULL
stimulation	NULL
of	NULL
the	NULL
IL-2	NULL
receptor	NULL
in	NULL
an	NULL
autocrine	NULL
or	NULL
paracrine	NULL
fash-ion	NULL
,	NULL
causing	NULL
T	NULL
cells	NULL
to	NULL
enter	NULL
S	NULL
phase	NULL
,	NULL
which	NULL
ultimately	NULL
results	NULL
in	NULL
cell	NULL
proliferation	NULL
.	NULL

Therefore	NULL
,	NULL
regulation	NULL
of	NULL
IL-2	NULL
gene	NULL
transcription	NULL
is	NULL
a	NULL
key	NULL
step	NULL
in	NULL
T-cell	NULL
activation	NULL
.	NULL

Two	NULL
critical	NULL
requirements	NULL
for	NULL
IL-2	NULL
gene	NULL
activation	NULL
upon	NULL
TCR	NULL
stimulation	NULL
are	NULL
the	NULL
activation	NULL
of	NULL
Ras	NULL
and	NULL
calcineurin	NULL
,	NULL
a	NULL
calcium/calmodulin-dependent	NULL
protein	NULL
phosphatase	NULL
(	NULL
10	NULL
,	NULL
13	NULL
,	NULL
47	NULL
,	NULL
51	NULL
)	NULL
.	NULL

It	NULL
is	NULL
believed	NULL
that	NULL
calcineurin	NULL
is	NULL
activated	NULL
by	NULL
the	NULL
increase	NULL
of	NULL
intracellular	NULL
calcium	NULL
4338	NULL
WU	NULL
ET	NULL
AL	NULL
.	NULL

caused	NULL
by	NULL
activation	NULL
of	NULL
PLC-y1	NULL
(	NULL
61	NULL
)	NULL
.	NULL

Two	NULL
pharmacological	NULL
agents	NULL
,	NULL
FK506	NULL
and	NULL
cyclosporin	NULL
A	NULL
,	NULL
can	NULL
block	NULL
TCR-mediated	NULL
IL-2	NULL
gene	NULL
activation	NULL
by	NULL
inhibiting	NULL
calcineurin	NULL
function	NULL
(	NULL
15	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Ras	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
PKC-dependent	NULL
and	NULL
PKC-indepen-dent	NULL
pathways	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
an	NULL
activated	NULL
form	NULL
of	NULL
Ras	NULL
leads	NULL
to	NULL
IL-2	NULL
gene	NULL
activation	NULL
in	NULL
conjunction	NULL
with	NULL
a	NULL
calcium	NULL
ionophore	NULL
or	NULL
an	NULL
activated	NULL
form	NULL
of	NULL
calcineurin	NULL
,	NULL
whereas	NULL
a	NULL
dominant	NULL
negative	NULL
form	NULL
of	NULL
Ras	NULL
inhibits	NULL
TCR	NULL
signaling	NULL
(	NULL
51	NULL
,	NULL
63	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
emphasize	NULL
the	NULL
critical	NULL
role	NULL
of	NULL
calcineurin	NULL
and	NULL
Ras	NULL
in	NULL
TCR-mediated	NULL
signals	NULL
that	NULL
regulate	NULL
IL-2	NULL
gene	NULL
expression	NULL
.	NULL

Although	NULL
p95¢	NULL
``	NULL
``	NULL
shares	NULL
homology	NULL
with	NULL
the	NULL
GEFs	NULL
for	NULL
Rho/	NULL
Rac	NULL
but	NULL
not	NULL
Ras	NULL
family	NULL
members	NULL
,	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
account	NULL
for	NULL
most	NULL
of	NULL
the	NULL
receptor-stimulated	NULL
Ras	NULL
GDP-GTP	NULL
exchange	NULL
activity	NULL
in	NULL
both	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
(	NULL
23	NULL
,	NULL
26	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
p95¢	NULL
``	NULL
``	NULL
or	NULL
binding	NULL
of	NULL
DAG	NULL
to	NULL
its	NULL
cysteine-rich	NULL
domain	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
required	NULL
for	NULL
this	NULL
exchange	NULL
activity	NULL
(	NULL
23-25	NULL
)	NULL
.	NULL

However	NULL
,	NULL
these	NULL
findings	NULL
have	NULL
not	NULL
been	NULL
confirmed	NULL
by	NULL
other	NULL
investigators	NULL
,	NULL
who	NULL
demonstrated	NULL
that	NULL
neither	NULL
p95¢	NULL
``	NULL
``	NULL
nor	NULL
oncogenic	NULL
vay	NULL
has	NULL
any	NULL
detectable	NULL
exchange	NULL
activity	NULL
for	NULL
Ras	NULL
and	NULL
that	NULL
the	NULL
morphology	NULL
of	NULL
vav-transformed	NULL
NIH	NULL
3T3	NULL
cells	NULL
is	NULL
distinct	NULL
that	NULL
of	NULL
from	NULL
Ras-transformed	NULL
cells	NULL
(	NULL
7	NULL
,	NULL
38	NULL
)	NULL
.	NULL

The	NULL
DAG	NULL
or	NULL
phorbol	NULL
ester	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
cysteine-rich	NULL
region	NULL
in	NULL
p95¢	NULL
``	NULL
``	NULL
also	NULL
appears	NULL
to	NULL
be	NULL
controversial	NULL
,	NULL
since	NULL
in	NULL
vitro	NULL
assays	NULL
failed	NULL
to	NULL
show	NULL
any	NULL
binding	NULL
of	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
to	NULL
DAG	NULL
or	NULL
phorbol	NULL
ester	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
functional	NULL
significance	NULL
of	NULL
p95	NULL
``	NULL
as	NULL
a	NULL
Ras	NULL
exchange	NULL
factor	NULL
in	NULL
lymphocytes	NULL
remains	NULL
unclear	NULL
.	NULL

To	NULL
explore	NULL
the	NULL
potential	NULL
role	NULL
of	NULL
p95	NULL
``	NULL
in	NULL
TCR-mediated	NULL
signaling	NULL
leading	NULL
to	NULL
IL-2	NULL
gene	NULL
activation	NULL
,	NULL
we	NULL
overexpressed	NULL
p95	NULL
``	NULL
and	NULL
oncogenic	NULL
vay	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
examined	NULL
their	NULL
effects	NULL
on	NULL
IL-2	NULL
promoter	NULL
elements	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
find	NULL
that	NULL
overexpression	NULL
of	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
alone	NULL
can	NULL
activate	NULL
the	NULL
IL-2	NULL
promoter	NULL
through	NULL
mechanisms	NULL
which	NULL
depend	NULL
on	NULL
both	NULL
Ras	NULL
and	NULL
calcineurin	NULL
function	NULL
.	NULL

By	NULL
using	NULL
various	NULL
Jurkat	NULL
mutants	NULL
deficient	NULL
in	NULL
TCR	NULL
signaling	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
this	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
activity	NULL
requires	NULL
a	NULL
functional	NULL
TCR	NULL
signaling	NULL
pathway	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
and	NULL
reagents	NULL
.	NULL

Jurkat	NULL
,	NULL
JCaM1.6	NULL
(	NULL
19	NULL
,	NULL
59	NULL
)	NULL
,	NULL
145.01	NULL
(	NULL
40	NULL
)	NULL
,	NULL
and	NULL
J.RT3-T3.5	NULL
(	NULL
46	NULL
)	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
penicillin	NULL
,	NULL
streptomycin	NULL
,	NULL
and	NULL
glutamine	NULL
(	NULL
medium	NULL
)	NULL
.	NULL

Simian	NULL
virus	NULL
40	NULL
(	NULL
SV40	NULL
)	NULL
T-antigen	NULL
(	NULL
TAg	NULL
)	NULL
-transfected	NULL
Jurkat	NULL
(	NULL
TAg	NULL
Jurkat	NULL
;	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
G.	NULL
Crabtree	NULL
)	NULL
,	NULL
J.HM1.2.1	NULL
(	NULL
20	NULL
)	NULL
,	NULL
J.HM1L.2.2	NULL
(	NULL
20	NULL
)	NULL
,	NULL
PF-2.4	NULL
,	NULL
and	NULL
PF-2.8	NULL
(	NULL
46	NULL
)	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
medium	NULL
with	NULL
2.0	NULL
mg	NULL
of	NULL
geneticin	NULL
(	NULL
Gibco	NULL
)	NULL
per	NULL
ml	NULL
and	NULL
transferred	NULL
to	NULL
geneticin-free	NULL
medium	NULL
48	NULL
h	NULL
before	NULL
experiments	NULL
to	NULL
prevent	NULL
aminoglycoside-mediated	NULL
inhibition	NULL
of	NULL
phosphoinositide	NULL
hydrolysis	NULL
.	NULL

JCaM1.6/Lck	NULL
cells	NULL
(	NULL
59	NULL
)	NULL
were	NULL
maintained	NULL
in	NULL
medium	NULL
containing	NULL
250	NULL
g	NULL
of	NULL
hygromycin	NULL
per	NULL
ml	NULL
.	NULL

Plasmids	NULL
.	NULL

The	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
and	NULL
oncogenic	NULL
vay	NULL
expression	NULL
plasmids	NULL
(	NULL
pSV115	NULL
and	NULL
pSV67	NULL
,	NULL
respectively	NULL
)	NULL
were	NULL
constructed	NULL
by	NULL
subcloning	NULL
the	NULL
EcoRI	NULL
fragments	NULL
of	NULL
vev	NULL
cDNAs	NULL
from	NULL
pSK115	NULL
and	NULL
pSK67	NULL
into	NULL
pSV7d	NULL
,	NULL
an	NULL
SV40	NULL
origin-containing	NULL
mammalian	NULL
expression	NULL
vector	NULL
(	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

The	NULL
same	NULL
cDNA	NULL
inserts	NULL
were	NULL
also	NULL
subcloned	NULL
into	NULL
pEF-BOS	NULL
,	NULL
another	NULL
mammalian	NULL
expression	NULL
vector	NULL
(	NULL
43	NULL
)	NULL
,	NULL
to	NULL
generate	NULL
pEF115	NULL
and	NULL
pEF67	NULL
.	NULL

An	NULL
oligonucleotide	NULL
fragment	NULL
comprising	NULL
both	NULL
a	NULL
Kozak	NULL
translational	NULL
initiation	NULL
and	NULL
the	NULL
myc	NULL
epitope	NULL
tag	NULL
sequences	NULL
was	NULL
linked	NULL
to	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
p95	NULL
``	NULL
cDNA	NULL
to	NULL
generate	NULL
both	NULL
pSV115myc	NULL
and	NULL
pEF115myc	NULL
.	NULL

Plasmid	NULL
pCD8T	NULL
,	NULL
expressing	NULL
only	NULL
the	NULL
extracellular	NULL
and	NULL
transmembrane	NULL
portion	NULL
of	NULL
the	NULL
human	NULL
CD8	NULL
«	NULL
molecule	NULL
,	NULL
has	NULL
been	NULL
described	NULL
elsewhere	NULL
(	NULL
30	NULL
)	NULL
.	NULL

The	NULL
N17ras	NULL
and	NULL
DN-Raf	NULL
plasmids	NULL
were	NULL
kind	NULL
gifts	NULL
from	NULL
D.	NULL
Cantrell	NULL
.	NULL

The	NULL
NFAT	NULL
,	NULL
NFIL-2A	NULL
,	NULL
and	NULL
IL-2	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
(	NULL
NFAT-Luc	NULL
,	NULL
NFIL2A-Luc	NULL
,	NULL
and	NULL
IL2-Luc	NULL
)	NULL
were	NULL
generous	NULL
gifts	NULL
from	NULL
G.	NULL
Crabtree	NULL
.	NULL

The	NULL
v-H-ras	NULL
expression	NULL
plasmid	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
H.	NULL
Bourne	NULL
.	NULL

Abs	NULL
.	NULL

The	NULL
monoclonal	NULL
antibody	NULL
(	NULL
MAb	NULL
)	NULL
used	NULL
for	NULL
the	NULL
stimulation	NULL
of	NULL
the	NULL
TCR	NULL
was	NULL
C305	NULL
,	NULL
which	NULL
recognizes	NULL
the	NULL
Jurkat	NULL
Ti	NULL
B	NULL
chain	NULL
(	NULL
62	NULL
)	NULL
.	NULL

The	NULL
anti-vay	NULL
polyclonal	NULL
antibody	NULL
(	NULL
Ab	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

Antiphosphotyrosine	NULL
MAb	NULL
4G10	NULL
was	NULL
purchased	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
Inc.	NULL
(	NULL
Lake	NULL
Placid	NULL
,	NULL
N.Y.	NULL
)	NULL
.	NULL

A	NULL
MAb	NULL
,	NULL
9E10	NULL
,	NULL
for	NULL
the	NULL
detection	NULL
of	NULL
the	NULL
myc	NULL
epitope	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
J.	NULL
M.	NULL
Bishop	NULL
.	NULL

A	NULL
fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
-conjugated	NULL
anti-CD8	NULL
«	NULL
(	NULL
FITC-CD8	NULL
)	NULL
Ab	NULL
was	NULL
purchased	NULL
from	NULL
Becton	NULL
Dickinson	NULL
(	NULL
Mountain	NULL
View	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

Cell	NULL
transfections	NULL
,	NULL
stimulations	NULL
,	NULL
and	NULL
luciferase	NULL
assays	NULL
.	NULL

TAg	NULL
Jurkat	NULL
cells	NULL
(	NULL
10°	NULL
)	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

were	NULL
transiently	NULL
transfected	NULL
by	NULL
electroporation	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
10	NULL
)	NULL
,	NULL
with	NULL
20	NULL
ug	NULL
of	NULL
the	NULL
reporter	NULL
plasmids	NULL
indicated	NULL
and	NULL
50	NULL
ug	NULL
of	NULL
a	NULL
vector	NULL
containing	NULL
either	NULL
no	NULL
insert	NULL
(	NULL
empty	NULL
vector	NULL
)	NULL
or	NULL
a	NULL
p95	NULL
``	NULL
,	NULL
N-terminally	NULL
truncated	NULL
vay	NULL
,	NULL
or	NULL
v-H-ras	NULL
cDNA	NULL
insert	NULL
.	NULL

Forty	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
10°	NULL
cells	NULL
were	NULL
aliquoted	NULL
into	NULL
a	NULL
96-well	NULL
plate	NULL
(	NULL
Corning	NULL
)	NULL
and	NULL
cultured	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
100	NULL
pl	NULL
of	NULL
RPMI	NULL
1640	NULL
growth	NULL
medium	NULL
.	NULL

Cells	NULL
were	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
at	NULL
37°C	NULL
in	NULL
growth	NULL
medium	NULL
containing	NULL
either	NULL
1.0	NULL
M	NULL
ionomycin	NULL
,	NULL
a	NULL
1:1,000	NULL
dilution	NULL
of	NULL
C305	NULL
ascites	NULL
,	NULL
500	NULL
pM	NULL
carbachol	NULL
,	NULL
or	NULL
50	NULL
ng	NULL
of	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
per	NULL
ml	NULL
and	NULL
1.0	NULL
M	NULL
iono-mycin	NULL
.	NULL

After	NULL
an	NULL
8-h	NULL
stimulation	NULL
period	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
harvest	NULL
buffer	NULL
(	NULL
100	NULL
mM	NULL
KPO	NULL
,	NULL
[	NULL
pH	NULL
7.8	NULL
]	NULL
,	NULL
1.0	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
)	NULL
,	NULL
and	NULL
100	NULL
pl	NULL
of	NULL
lysate	NULL
was	NULL
mixed	NULL
with	NULL
100	NULL
pl	NULL
of	NULL
assay	NULL
buffer	NULL
(	NULL
200	NULL
mM	NULL
KPO	NULL
,	NULL
[	NULL
pH	NULL
7.8	NULL
]	NULL
,	NULL
10	NULL
mM	NULL
ATP	NULL
,	NULL
20	NULL
mM	NULL
MgCl	NULL
)	NULL
followed	NULL
by	NULL
100	NULL
pl	NULL
of	NULL
1.0	NULL
mM	NULL
luciferin	NULL
.	NULL

Luciferase	NULL
activity	NULL
,	NULL
expressed	NULL
in	NULL
arbitrary	NULL
units	NULL
(	NULL
AU	NULL
)	NULL
,	NULL
was	NULL
determined	NULL
either	NULL
in	NULL
duplicate	NULL
or	NULL
in	NULL
triplicate	NULL
for	NULL
each	NULL
experimental	NULL
condition	NULL
.	NULL

In	NULL
the	NULL
cotransfection	NULL
experiments	NULL
,	NULL
30	NULL
g	NULL
of	NULL
a	NULL
vector	NULL
containing	NULL
either	NULL
N17ras	NULL
,	NULL
DN-Raf	NULL
,	NULL
or	NULL
pCD8T	NULL
was	NULL
cotransfected	NULL
with	NULL
pSV115	NULL
.	NULL

For	NULL
wild-type	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
mutant	NULL
derivatives	NULL
,	NULL
plasmid	NULL
pEF115	NULL
or	NULL
pEF115myc	NULL
(	NULL
40	NULL
pg	NULL
)	NULL
was	NULL
transiently	NULL
transfected	NULL
into	NULL
10	NULL
``	NULL
cells	NULL
.	NULL

Forty	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
aliquoted	NULL
into	NULL
a	NULL
24-well	NULL
plates	NULL
in	NULL
1.5	NULL
ml	NULL
of	NULL
medium	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
stimulated	NULL
and	NULL
assayed	NULL
as	NULL
described	NULL
above	NULL
.	NULL

For	NULL
the	NULL
inhibition	NULL
assays	NULL
,	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
medium	NULL
containing	NULL
either	NULL
100	NULL
ng	NULL
of	NULL
FK506	NULL
per	NULL
ml	NULL
or	NULL
3.0	NULL
wM	NULL
herbimycin	NULL
A	NULL
for	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

They	NULL
were	NULL
stimulated	NULL
and	NULL
assayed	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Cell	NULL
purification	NULL
and	NULL
immunoblots	NULL
.	NULL

TAg	NULL
Jurkat	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
pCDS8T	NULL
,	NULL
along	NULL
with	NULL
an	NULL
empty	NULL
vector	NULL
,	NULL
pSV115	NULL
or	NULL
pSV67	NULL
.	NULL

Twenty-four	NULL
hours	NULL
later	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
CD8-positive	NULL
cells	NULL
were	NULL
enriched	NULL
by	NULL
adding	NULL
FITC-CD8	NULL
Ab	NULL
and	NULL
sheep	NULL
anti-mouse	NULL
immunoglobulin-coated	NULL
magnetic	NULL
beads	NULL
(	NULL
Dynal	NULL
Inc.	NULL
,	NULL
Great	NULL
Neck	NULL
,	NULL
N.Y.	NULL
)	NULL
.	NULL

The	NULL
bound	NULL
CD8-positive	NULL
cells	NULL
were	NULL
then	NULL
lysed	NULL
in	NULL
lysis	NULL
buffer	NULL
containing	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
10	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.8	NULL
)	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
protease	NULL
and	NULL
phosphatase	NULL
inhibitors	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
59	NULL
)	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
TCR	NULL
stimulation	NULL
,	NULL
CD8-positive	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
C305	NULL
(	NULL
1:250	NULL
)	NULL
for	NULL
2	NULL
min	NULL
and	NULL
then	NULL
lysed	NULL
immediately	NULL
.	NULL

Lysates	NULL
equivalent	NULL
to	NULL
10°	NULL
cells	NULL
were	NULL
separated	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophore-sis	NULL
and	NULL
were	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
blocked	NULL
with	NULL
5	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
or	NULL
3	NULL
%	NULL
ovalbumin	NULL
)	NULL
in	NULL
10	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
-150	NULL
mM	NULL
NaCl	NULL
containixllg	NULL
0.05	NULL
%	NULL
Tween	NULL
detergent	NULL
.	NULL

Blots	NULL
were	NULL
incubated	NULL
with	NULL
primary	NULL
Ab	NULL
followed	NULL
by	NULL
[	NULL
***IJprotein	NULL
A	NULL
or	NULL
secondary	NULL
Ab	NULL
conjugated	NULL
with	NULL
horseradish	NULL
peroxidase	NULL
and	NULL
then	NULL
assayed	NULL
by	NULL
autoradiography	NULL
or	NULL
enhanced	NULL
chemilumines-cence	NULL
assay	NULL
,	NULL
(	NULL
ECL	NULL
kit	NULL
;	NULL
Amersham	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Measurement	NULL
of	NULL
calcium	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Calcium	NULL
measurements	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
indicated	NULL
transiently	NULL
transfected	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
media	NULL
at	NULL
10	NULL
%	NULL
/ml	NULL
with	NULL
a	NULL
1.0	NULL
wM	NULL
the	NULL
calcium-sensitive	NULL
fluorescence	NULL
dye	NULL
Indo-1	NULL
(	NULL
Molecular	NULL
Probe	NULL
,	NULL
Menlo	NULL
Park	NULL
,	NULL
Calif.	NULL
)	NULL
at	NULL
37°C	NULL
and	NULL
then	NULL
stained	NULL
with	NULL
FITC-CD8	NULL
Ab	NULL
at	NULL
4°C	NULL
.	NULL

Fluorescence-activated	NULL
cell	NULL
sorter	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
4	NULL
)	NULL
.	NULL

RESULTS	NULL
Overexpression	NULL
of	NULL
p95°	NULL
``	NULL
``	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
increases	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
IL-2	NULL
promoter	NULL
elements	NULL
and	NULL
further	NULL
potentiates	NULL
TCR-mediated	NULL
signal	NULL
transduction	NULL
.	NULL

TCR	NULL
activation	NULL
contributes	NULL
to	NULL
the	NULL
production	NULL
of	NULL
IL-2	NULL
.	NULL

cis-acting	NULL
elements	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
bind	NULL
nuclear	NULL
factors	NULL
,	NULL
including	NULL
NFAT	NULL
and	NULL
NFIL-ZA	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Reporter	NULL
constructs	NULL
containing	NULL
multimers	NULL
of	NULL
cither	NULL
element	NULL
are	NULL
responsive	NULL
to	NULL
TCR-mediated	NULL
signaling	NULL
and	NULL
require	NULL
activation	NULL
of	NULL
both	NULL
calcineurin	NULL
and	NULL
Ras	NULL
pathways	NULL
(	NULL
14	NULL
,	NULL
15	NULL
,	NULL
63	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
role	NULL
of	NULL
p95	NULL
``	NULL
in	NULL
T-cell	NULL
signaling	NULL
,	NULL
we	NULL
transiently	NULL
overexpressed	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
in	NULL
SV40	NULL
TAg-transfected	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
examined	NULL
its	NULL
effect	NULL
on	NULL
the	NULL
NFAT-Luc	NULL
or	NULL
NFILZA-Luc	NULL
reporter	NULL
construct	NULL
.	NULL

The	NULL
expression	NULL
vector	NULL
used	NULL
contains	NULL
an	NULL
SV40	NULL
origin	NULL
of	NULL
replication	NULL
to	NULL
allow	NULL
its	NULL
high-level	NULL
gene	NULL
expression	NULL
in	NULL
TAg	NULL
Jurkat	NULL
cells	NULL
(	NULL
10	NULL
)	NULL
.	NULL

By	NULL
cotransfecting	NULL
truncated	NULL
CD8	NULL
as	NULL
a	NULL
surface	NULL
marker	NULL
for	NULL
transfected	NULL
cells	NULL
and	NULL
then	NULL
enriching	NULL
the	NULL
CD8-positive	NULL
transfectants	NULL
,	NULL
we	NULL
estimated	NULL
that	NULL
the	NULL
level	NULL
of	NULL
p95¢	NULL
``	NULL
``	NULL
overexpression	NULL
is	NULL
about	NULL
5	NULL
to	NULL
10	NULL
times	NULL
that	NULL
of	NULL
the	NULL
endogenous	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
by	NULL
Western	NULL
blotting	NULL
(	NULL
immuno-blotting	NULL
)	NULL
and	NULL
autoradiography	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
p95	NULL
``	NULL
alone	NULL
resulted	NULL
in	NULL
30-	NULL
and	NULL
15-fold	NULL
increases	NULL
in	NULL
basal	NULL
activity	NULL
of	NULL
the	NULL
NFAT	NULL
and	NULL
NFIL-2A	NULL
reporter	NULL
constructs	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
reporter	NULL
constructs	NULL
driven	NULL
by	NULL
a	NULL
constitutively	NULL
active	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
promoter	NULL
or	NULL
CD4	NULL
enhancer	NULL
promoter	NULL
produced	NULL
only	NULL
a	NULL
twofold	NULL
increase	NULL
of	NULL
activity	NULL
in	NULL
the	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
-overexpressing	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
a	NULL
truncated	NULL
form	NULL
of	NULL
p95¢	NULL
``	NULL
``	NULL
,	NULL
lacking	NULL
the	NULL
first	NULL
67	NULL
amino	NULL
acids	NULL
in	NULL
the	NULL
N	NULL
terminus	NULL
,	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
increases	NULL
Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
A	NULL
106-	NULL
watts	NULL
<	NULL
pgsvay	NULL
80	NULL
-	NULL
-e	NULL
<	NULL
-	NULL
oncogenic	NULL
vay	NULL
1	NULL
2	NULL
3	NULL
200	NULL
7	NULL
[	NULL
]	NULL
vector	NULL
B	NULL
p9Svav	NULL
5	NULL
o	NULL
'	NULL
B	NULL
0	NULL
3	NULL
B	NULL
==	NULL
100	NULL
-3	NULL
s	NULL
Lik	NULL
.	NULL

0	NULL
Unstimulated	NULL
Anti-TCR	NULL
NFAT-~Luciferase	NULL
Induction	NULL
Fold	NULL
Induction	NULL
Fold	NULL
p95	NULL
``	NULL
IN	NULL
TCR	NULL
SIGNALING	NULL
4339	NULL
30	NULL
[	NULL
]	NULL
vector	NULL
W	NULL
pQ9S5vav	NULL
N-trunc	NULL
.	NULL

vav	NULL
20	NULL
10	NULL
7	NULL
0	NULL
a	NULL
.	NULL

NFAT	NULL
NFIL-2A	NULL
Reporter	NULL
Plasmid	NULL
[	NULL
]	NULL
vector	NULL
20	NULL
4	NULL
n	NULL
p95vav	NULL
10	NULL
7	NULL
0	NULL
Anti-TCR	NULL
IL-2	NULL
Luciferase	NULL
Unstimulated	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Overexpression	NULL
of	NULL
p95	NULL
``	NULL
in	NULL
TAg	NULL
Jurkat	NULL
cells	NULL
augments	NULL
basal	NULL
and	NULL
TCR-stimulated	NULL
IL-2	NULL
transcriptional	NULL
activity	NULL
.	NULL

(	NULL
A	NULL
)	NULL
TAg	NULL
Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
plasmids	NULL
encoding	NULL
pCD	NULL
#	NULL
/T	NULL
together	NULL
with	NULL
either	NULL
an	NULL
empty	NULL
vector	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
wild-type	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
or	NULL
N-terminally	NULL
truncated	NULL
vay	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

CD8-positive	NULL
cells	NULL
were	NULL
purified	NULL
,	NULL
normalized	NULL
,	NULL
and	NULL
blotted	NULL
for	NULL
vay	NULL
expression	NULL
.	NULL

Sizes	NULL
are	NULL
indicated	NULL
in	NULL
kilodaltons	NULL
.	NULL

(	NULL
B	NULL
)	NULL
TAg	NULL
Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
either	NULL
NFAT-Luc	NULL
or	NULL
NFIL2A-Luc	NULL
together	NULL
with	NULL
either	NULL
an	NULL
empty	NULL
vector	NULL
,	NULL
wild-type	NULL
p95	NULL
``	NULL
,	NULL
or	NULL
N-terminally	NULL
truncated	NULL
(	NULL
N-trunc	NULL
.	NULL
)	NULL

vay	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
then	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
TAg	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
either	NULL
NFAT-Luc	NULL
(	NULL
C	NULL
)	NULL
or	NULL
IL2-Luc	NULL
(	NULL
D	NULL
)	NULL
,	NULL
along	NULL
with	NULL
either	NULL
an	NULL
empty	NULL
vector	NULL
or	NULL
wild-type	NULL
p95	NULL
``	NULL
.	NULL

Cells	NULL
were	NULL
either	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
an	NULL
anti-TCR	NULL
MAb	NULL
(	NULL
C305	NULL
)	NULL
and	NULL
then	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

The	NULL
results	NULL
are	NULL
shown	NULL
as	NULL
the	NULL
fold	NULL
induction	NULL
of	NULL
luciferase	NULL
activity	NULL
compared	NULL
with	NULL
the	NULL
activity	NULL
in	NULL
unstimulated	NULL
cells	NULL
cotransfected	NULL
with	NULL
pSV	NULL
7d	NULL
empty	NULL
vector	NULL
and	NULL
the	NULL
reporter	NULL
construct	NULL
.	NULL

Luciferase	NULL
activities	NULL
of	NULL
the	NULL
unstimulated	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
were	NULL
approximately	NULL
500	NULL
AU	NULL
for	NULL
NFAT-Luc	NULL
and	NULL
200	NULL
AU	NULL
for	NULL
either	NULL
NFIL2A-Luc	NULL
or	NULL
IL2-Luc	NULL
.	NULL

Maximal	NULL
stimulated	NULL
activities	NULL
(	NULL
by	NULL
treatment	NULL
with	NULL
50	NULL
ng	NULL
of	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
per	NULL
ml	NULL
and	NULL
1.0	NULL
wM	NULL
ionomycin	NULL
)	NULL
were	NULL
typically	NULL
about	NULL
10°	NULL
AU	NULL
for	NULL
NFAT-Luc	NULL
and	NULL
5	NULL
X	NULL
10*	NULL
AU	NULL
for	NULL
either	NULL
NFIL2A-Lue	NULL
or	NULL
IL2-Lue	NULL
.	NULL

The	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
of	NULL
values	NULL
determined	NULL
from	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

Error	NULL
bars	NULL
represent	NULL
standard	NULL
errors	NULL
of	NULL
the	NULL
means	NULL
.	NULL

in	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
either	NULL
NFAT	NULL
or	NULL
NFIL-2A	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

The	NULL
overexpression	NULL
level	NULL
of	NULL
the	NULL
truncated	NULL
vay	NULL
is	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
wild	NULL
type	NULL
p95¢	NULL
``	NULL
``	NULL
in	NULL
TAg	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

This	NULL
result	NULL
was	NULL
surprising	NULL
,	NULL
since	NULL
the	NULL
truncated	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
is	NULL
transforming	NULL
in	NULL
fibroblasts	NULL
,	NULL
but	NULL
indicates	NULL
that	NULL
the	NULL
effect	NULL
observed	NULL
with	NULL
the	NULL
full-length	NULL
p95¢	NULL
``	NULL
``	NULL
does	NULL
not	NULL
simply	NULL
reflect	NULL
the	NULL
overexpression	NULL
of	NULL
domains	NULL
(	NULL
such	NULL
as	NULL
SH2	NULL
and	NULL
SH3	NULL
domains	NULL
)	NULL
shared	NULL
by	NULL
other	NULL
signaling	NULL
molecules	NULL
.	NULL

Moreover	NULL
,	NULL
it	NULL
implies	NULL
that	NULL
the	NULL
N-terminal	NULL
region	NULL
may	NULL
be	NULL
required	NULL
for	NULL
p95¢	NULL
``	NULL
``	NULL
function	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Not	NULL
only	NULL
did	NULL
overexpression	NULL
of	NULL
p95¢	NULL
``	NULL
``	NULL
lead	NULL
to	NULL
NFAT	NULL
activation	NULL
without	NULL
TCR	NULL
stimulation	NULL
,	NULL
it	NULL
also	NULL
markedly	NULL
augmented	NULL
TCR-stimulated	NULL
NFAT	NULL
activity	NULL
compared	NULL
with	NULL
the	NULL
level	NULL
in	NULL
the	NULL
control	NULL
vector-transfected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
10-fold	NULL
augmentation	NULL
was	NULL
observed	NULL
on	NULL
TCR-mediated	NULL
induction	NULL
of	NULL
a	NULL
reporter	NULL
construct	NULL
containing	NULL
the	NULL
entire	NULL
upstream	NULL
275	NULL
bp	NULL
of	NULL
the	NULL
IL-2	NULL
regulatory	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

1D	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
TCR	NULL
stimulation	NULL
alone	NULL
failed	NULL
to	NULL
activate	NULL
the	NULL
IL-2	NULL
promoter	NULL
in	NULL
this	NULL
experiment	NULL
because	NULL
costimulation	NULL
with	NULL
phorbol	NULL
ester	NULL
or	NULL
CD28	NULL
stimulation	NULL
is	NULL
required	NULL
for	NULL
activation	NULL
of	NULL
this	NULL
promoter	NULL
construct	NULL
.	NULL

Overexpression	NULL
of	NULL
the	NULL
N-terminal	NULL
truncated	NULL
vay	NULL
failed	NULL
to	NULL
enhance	NULL
TCR-mediated	NULL
signal	NULL
transduction	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
p95¢	NULL
``	NULL
-induced	NULL
NFAT	NULL
activation	NULL
is	NULL
not	NULL
due	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
TAg	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
since	NULL
we	NULL
also	NULL
obtained	NULL
similar	NULL
results	NULL
when	NULL
we	NULL
overexpressed	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
in	NULL
unmodified	NULL
(	NULL
lacking	NULL
TAg	NULL
expres-sion	NULL
)	NULL
Jurkat	NULL
cells	NULL
by	NULL
using	NULL
a	NULL
different	NULL
mammalian	NULL
expression	NULL
vector	NULL
,	NULL
pEF-BOS	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
that	NULL
overexpression	NULL
of	NULL
p95¢	NULL
``	NULL
``	NULL
has	NULL
a	NULL
profound	NULL
effect	NULL
on	NULL
TCR-mediated	NULL
activation	NULL
of	NULL
factors	NULL
involved	NULL
in	NULL
IL-2	NULL
gene	NULL
regulation	NULL
and	NULL
allowed	NULL
us	NULL
to	NULL
study	NULL
further	NULL
the	NULL
signaling	NULL
role	NULL
of	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

4340	NULL
WU	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
200	NULL
{	NULL
vector	NULL
K	NULL
|	NULL
p9Svav	NULL
c	NULL
v-H-ras	NULL
o	NULL
3	NULL
-	NULL
1507	NULL
G	NULL
3	NULL
hE	NULL
3	NULL
100	NULL
{	NULL
C	NULL
Ld	NULL
.	NULL

l—	NULL
<	NULL
Lis	NULL
Z	NULL
50	NULL
p	NULL
|	NULL
--	NULL
--	NULL
l-Unstimulated	NULL
_	NULL
lonomycin	NULL
Anti-	NULL
TCR	NULL
Stimulation	NULL
(	NULL
o	NULL
warr	NULL
cme	NULL
<	NULL
4	NULL
pg5vav	NULL
1	NULL
2	NULL
3	NULL
aap	NULL
@	NULL
i	NULL
.	NULL

40	NULL
poSVoV	NULL
1	NULL
2	NULL
3	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

B	NULL
[	NULL
]	NULL
vector	NULL
,	NULL
unstimulated	NULL
1507	NULL
E	NULL
posvav	NULL
,	NULL
unstimulated	NULL
c	NULL
.0	NULL
BB	NULL
vector	NULL
,	NULL
anti-TCR	NULL
't	NULL
g	NULL
pgsvav	NULL
,	NULL
anti-TCR	NULL
G	NULL
€	NULL
100-C	NULL
0	NULL
L.	NULL
a	NULL
ind	NULL
507	NULL
22	NULL
p	NULL
L	NULL
--	NULL
§	NULL
r	NULL
3	NULL
Control	NULL
DNA	NULL
N17ras	NULL
DN-Raf	NULL
Cotransfection	NULL
D	NULL
-	NULL
250	NULL
[	NULL
]	NULL
vector	NULL
,	NULL
-	NULL
unstimulated	NULL
e	NULL
p9Svav	NULL
,	NULL
unstimulated	NULL
o-9	NULL
20	NULL
B	NULL
vecior	NULL
,	NULL
anti-tcR	NULL
o	NULL
3	NULL
p9Svav	NULL
,	NULL
anti-TCR	NULL
G	NULL
c	NULL
-=	NULL
0	NULL
1504	NULL
C	NULL
0	NULL
[	NULL
nd	NULL
L0	NULL
1997	NULL
<	NULL
LL	NULL
4	NULL
507	NULL
o	NULL
-	NULL
+	NULL
FK506	NULL
Treatment	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

NFAT	NULL
activation	NULL
is	NULL
not	NULL
mimicked	NULL
by	NULL
Ras	NULL
activation	NULL
but	NULL
is	NULL
dependent	NULL
on	NULL
Ras	NULL
and	NULL
calcineurin	NULL
function	NULL
.	NULL

(	NULL
A	NULL
)	NULL
TAg	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
NFAT-Luc	NULL
along	NULL
with	NULL
either	NULL
an	NULL
empty	NULL
vector	NULL
alone	NULL
,	NULL
p95	NULL
``	NULL
,	NULL
or	NULL
v-H-ras	NULL
.	NULL

Cells	NULL
were	NULL
either	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
ionomycin	NULL
or	NULL
an	NULL
anti-TCR	NULL
MAb	NULL
(	NULL
C305	NULL
)	NULL
and	NULL
then	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

The	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
means	NULL
of	NULL
values	NULL
determined	NULL
from	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

Error	NULL
bars	NULL
represent	NULL
standard	NULL
errors	NULL
of	NULL
the	NULL
means	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Cotransfection	NULL
of	NULL
N17ras	NULL
or	NULL
DN-Raf	NULL
impairs	NULL
the	NULL
basal	NULL
and	NULL
TCR-mediated	NULL
NFAT	NULL
activation	NULL
induced	NULL
by	NULL
p95	NULL
``	NULL
overexpression	NULL
in	NULL
TAg	NULL
Jurkat	NULL
cells	NULL
.	NULL

A	NULL
control	NULL
vector	NULL
,	NULL
N17ras	NULL
,	NULL
or	NULL
DN-Raf	NULL
was	NULL
cotransfected	NULL
into	NULL
TAg	NULL
Jurkat	NULL
cells	NULL
with	NULL
either	NULL
a	NULL
control	NULL
vector	NULL
or	NULL
myc-p95	NULL
``	NULL
along	NULL
with	NULL
NFAT-Luc	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
stimulated	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

(	NULL
C	NULL
)	NULL
An	NULL
aliquot	NULL
of	NULL
cells	NULL
from	NULL
each	NULL
transfection	NULL
in	NULL
panel	NULL
B	NULL
was	NULL
lysed	NULL
and	NULL
blotted	NULL
for	NULL
mye	NULL
epitope	NULL
.	NULL

Lanes	NULL
1	NULL
through	NULL
3	NULL
represent	NULL
myc-p95	NULL
``	NULL
``	NULL
``	NULL
plus	NULL
vector	NULL
,	NULL
myc-p95	NULL
``	NULL
``	NULL
``	NULL
plus	NULL
N17ras	NULL
,	NULL
and	NULL
myc-p95	NULL
``	NULL
``	NULL
``	NULL
plus	NULL
DN-Raf	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
D	NULL
)	NULL
TAg	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
NFAT-Luc	NULL
along	NULL
with	NULL
either	NULL
a	NULL
control	NULL
vector	NULL
or	NULL
myc-p95	NULL
``	NULL
``	NULL
,	NULL
stimulated	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
FK506	NULL
,	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

(	NULL
E	NULL
)	NULL
An	NULL
aliquot	NULL
of	NULL
transfected	NULL
cells	NULL
in	NULL
panel	NULL
D	NULL
was	NULL
lysed	NULL
and	NULL
blotted	NULL
for	NULL
the	NULL
myc	NULL
epitope	NULL
.	NULL

Lane	NULL
1	NULL
through	NULL
3	NULL
represent	NULL
control	NULL
vector	NULL
,	NULL
and	NULL
myc-p95	NULL
``	NULL
``	NULL
``	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
FK506	NULL
,	NULL
respectively	NULL
.	NULL

All	NULL
luciferase	NULL
assay	NULL
results	NULL
are	NULL
shown	NULL
as	NULL
the	NULL
fold	NULL
induction	NULL
of	NULL
luciferase	NULL
activity	NULL
compared	NULL
with	NULL
the	NULL
activity	NULL
in	NULL
unstimulated	NULL
cells	NULL
cotransfected	NULL
with	NULL
pSV7d	NULL
vector	NULL
and	NULL
NFAT-Luc	NULL
.	NULL

The	NULL
data	NULL
are	NULL
representative	NULL
of	NULL
at	NULL
least	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

Rather	NULL
than	NULL
simply	NULL
activating	NULL
Ras	NULL
alone	NULL
,	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
appears	NULL
to	NULL
function	NULL
upstream	NULL
of	NULL
or	NULL
parallel	NULL
to	NULL
Ras	NULL
and	NULL
calcineurin	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
minimum	NULL
requirement	NULL
for	NULL
NFAT	NULL
induction	NULL
is	NULL
activation	NULL
of	NULL
both	NULL
Ras	NULL
and	NULL
calcineurin	NULL
(	NULL
63	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
a	NULL
constitutively	NULL
activated	NULL
Ras	NULL
protein	NULL
,	NULL
v-H-ras	NULL
,	NULL
generates	NULL
a	NULL
signal	NULL
which	NULL
can	NULL
synergize	NULL
with	NULL
a	NULL
calcium	NULL
signal	NULL
to	NULL
induce	NULL
NFAT	NULL
(	NULL
51	NULL
,	NULL
63	NULL
)	NULL
.	NULL

Since	NULL
a	NULL
region	NULL
of	NULL
p95	NULL
``	NULL
shares	NULL
homology	NULL
with	NULL
GEF	NULL
domains	NULL
for	NULL
the	NULL
Rho/Rac	NULL
family	NULL
of	NULL
small	NULL
GTPases	NULL
and	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
a	NULL
Ras	NULL
GEF	NULL
in	NULL
lymphocytes	NULL
,	NULL
one	NULL
possibility	NULL
is	NULL
that	NULL
p95	NULL
``	NULL
overexpression	NULL
in	NULL
T	NULL
cells	NULL
directly	NULL
activates	NULL
Ras	NULL
.	NULL

It	NULL
might	NULL
then	NULL
be	NULL
expected	NULL
to	NULL
further	NULL
synergize	NULL
with	NULL
a	NULL
basal	NULL
calcineurin	NULL
activity	NULL
leading	NULL
to	NULL
NFAT	NULL
activation	NULL
.	NULL

Unlike	NULL
p95	NULL
``	NULL
``	NULL
**	NULL
,	NULL
transfection	NULL
of	NULL
v-H-ras	NULL
into	NULL
TAg	NULL
Jurkat	NULL
cells	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
a	NULL
significant	NULL
basal	NULL
stimulation	NULL
of	NULL
NFAT	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

More	NULL
over	NULL
,	NULL
ionomycin	NULL
,	NULL
a	NULL
calcium	NULL
ionophore	NULL
which	NULL
activates	NULL
calcineurin	NULL
,	NULL
strongly	NULL
synergized	NULL
with	NULL
v-H-ras	NULL
but	NULL
not	NULL
with	NULL
p95¢	NULL
``	NULL
``	NULL
in	NULL
NFAT	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
recent	NULL
report	NULL
showing	NULL
that	NULL
p95¢	NULL
``	NULL
``	NULL
does	NULL
not	NULL
directly	NULL
activate	NULL
Ras	NULL
(	NULL
7	NULL
)	NULL
.	NULL

However	NULL
,	NULL
Ras	NULL
could	NULL
still	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
effects	NULL
of	NULL
p95Y	NULL
``	NULL
``	NULL
overexpression	NULL
.	NULL

Since	NULL
expression	NULL
of	NULL
either	NULL
a	NULL
dominant	NULL
negative	NULL
Ras	NULL
(	NULL
N17ras	NULL
)	NULL
or	NULL
a	NULL
dominant	NULL
negative	NULL
Raf	NULL
(	NULL
DN-Raf	NULL
)	NULL
prevents	NULL
TCR-mediated	NULL
activation	NULL
of	NULL
NFAT	NULL
and	NULL
the	NULL
IL-2	NULL
gene	NULL
(	NULL
48	NULL
,	NULL
51	NULL
)	NULL
,	NULL
we	NULL
coexpressed	NULL
N1l7ras	NULL
or	NULL
DN-Raf	NULL
along	NULL
with	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
in	NULL
TAg	NULL
Jurkat	NULL
cells	NULL
to	NULL
examine	NULL
whether	NULL
p95¢	NULL
``	NULL
``	NULL
may	NULL
depend	NULL
on	NULL
the	NULL
Ras	NULL
pathway	NULL
to	NULL
exert	NULL
its	NULL
activity	NULL
on	NULL
NFAT	NULL
.	NULL

To	NULL
monitor	NULL
the	NULL
level	NULL
of	NULL
p95¢	NULL
``	NULL
``	NULL
overexpression	NULL
,	NULL
we	NULL
generated	NULL
a	NULL
myc	NULL
epitope-tagged	NULL
version	NULL
of	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
.	NULL

Coexpression	NULL
of	NULL
either	NULL
N1l7ras	NULL
or	NULL
DN-Raf	NULL
abol-	NULL
Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
ished	NULL
the	NULL
elevated	NULL
basal	NULL
and	NULL
TCR-mediated	NULL
NFAT	NULL
activity	NULL
induced	NULL
by	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
overexpression	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
but	NULL
did	NULL
not	NULL
suppress	NULL
the	NULL
level	NULL
of	NULL
transfected	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
p95¢	NULL
``	NULL
``	NULL
does	NULL
not	NULL
simply	NULL
function	NULL
to	NULL
directly	NULL
activate	NULL
Ras	NULL
;	NULL
rather	NULL
,	NULL
it	NULL
appears	NULL
to	NULL
influence	NULL
signaling	NULL
events	NULL
that	NULL
depend	NULL
upon	NULL
Ras	NULL
function	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
-induced	NULL
activation	NULL
of	NULL
NFAT	NULL
also	NULL
requires	NULL
calcineurin	NULL
function	NULL
,	NULL
we	NULL
used	NULL
two	NULL
immu-nosuppressive	NULL
agents	NULL
,	NULL
FK506	NULL
and	NULL
cyclosporin	NULL
A	NULL
,	NULL
which	NULL
are	NULL
known	NULL
to	NULL
inhibit	NULL
calcineurin	NULL
function	NULL
and	NULL
thus	NULL
impair	NULL
TCR-mediated	NULL
NFAT	NULL
activation	NULL
(	NULL
15	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
Jurkat	NULL
cells	NULL
with	NULL
either	NULL
FK506	NULL
or	NULL
cyclosporin	NULL
A	NULL
completely	NULL
blocked	NULL
both	NULL
the	NULL
elevation	NULL
of	NULL
basal	NULL
levels	NULL
and	NULL
TCR-mediated	NULL
NFAT	NULL
activation	NULL
in	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
-overexpressing	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
drug	NULL
treatment	NULL
was	NULL
not	NULL
toxic	NULL
to	NULL
the	NULL
cells	NULL
and	NULL
did	NULL
not	NULL
inhibit	NULL
p95¢	NULL
``	NULL
``	NULL
overexpression	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2E	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
NFAT	NULL
activation	NULL
in	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
-overexpressing	NULL
cells	NULL
depends	NULL
on	NULL
both	NULL
Ras	NULL
and	NULL
calcineurin	NULL
pathways	NULL
and	NULL
suggest	NULL
that	NULL
p95	NULL
``	NULL
may	NULL
function	NULL
upstream	NULL
of	NULL
or	NULL
parallel	NULL
to	NULL
them	NULL
in	NULL
TCR	NULL
signaling	NULL
pathways	NULL
.	NULL

The	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
activity	NULL
appears	NULL
to	NULL
be	NULL
specific	NULL
to	NULL
TCR-mediated	NULL
signaling	NULL
.	NULL

TCR	NULL
engagement	NULL
induces	NULL
PLC	NULL
activity	NULL
,	NULL
which	NULL
leads	NULL
to	NULL
the	NULL
hydrolysis	NULL
of	NULL
phosphatidylinositol	NULL
4,5-bisphosphate	NULL
and	NULL
generation	NULL
of	NULL
inositol	NULL
1,4,5-trisphosphate	NULL
and	NULL
DAG	NULL
.	NULL

These	NULL
second	NULL
messengers	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
rapid	NULL
and	NULL
sustained	NULL
intracellular	NULL
calcium	NULL
increase	NULL
and	NULL
activation	NULL
of	NULL
PKC	NULL
upon	NULL
TCR	NULL
stimulation	NULL
,	NULL
respectively	NULL
(	NULL
61	NULL
)	NULL
.	NULL

The	NULL
calcium	NULL
increase	NULL
is	NULL
believed	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
activation	NULL
of	NULL
calcineurin	NULL
,	NULL
whereas	NULL
PKC	NULL
activation	NULL
can	NULL
lead	NULL
to	NULL
Ras	NULL
activation	NULL
(	NULL
61	NULL
)	NULL
.	NULL

In	NULL
J.HM1.2.2	NULL
,	NULL
a	NULL
Jurkat	NULL
T-cell	NULL
line	NULL
expressing	NULL
the	NULL
seven-transmem-brane	NULL
domain	NULL
heterologous	NULL
human	NULL
muscarinic	NULL
receptor	NULL
(	NULL
HMIR	NULL
)	NULL
,	NULL
PLC-	NULL
is	NULL
believed	NULL
to	NULL
be	NULL
activated	NULL
by	NULL
the	NULL
HMIR	NULL
via	NULL
a	NULL
heterotrimeric	NULL
G-protein-mediated	NULL
mechanism	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
the	NULL
HMIR	NULL
in	NULL
Jurkat	NULL
cells	NULL
induces	NULL
increases	NULL
in	NULL
intracellular	NULL
Ca**	NULL
concentration	NULL
and	NULL
Ras	NULL
activation	NULL
(	NULL
reference	NULL
20	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
overexpression	NULL
in	NULL
J.HM1.2.2	NULL
cells	NULL
,	NULL
in	NULL
which	NULL
stimulation	NULL
through	NULL
either	NULL
TCR	NULL
or	NULL
HMIR	NULL
can	NULL
cause	NULL
IL-2	NULL
gene	NULL
activation	NULL
.	NULL

Consistent	NULL
with	NULL
previous	NULL
studies	NULL
,	NULL
carbachol	NULL
stimulation	NULL
of	NULL
the	NULL
HMIR	NULL
led	NULL
to	NULL
a	NULL
potent	NULL
induction	NULL
of	NULL
NFAT	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Strikingly	NULL
,	NULL
overexpression	NULL
of	NULL
p95	NULL
``	NULL
failed	NULL
to	NULL
augment	NULL
the	NULL
HMIR	NULL
stimulation	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
its	NULL
effect	NULL
on	NULL
TCR-mediated	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
overexpression	NULL
of	NULL
p95¢	NULL
``	NULL
``	NULL
in	NULL
Jurkat	NULL
cells	NULL
had	NULL
only	NULL
minimal	NULL
effects	NULL
on	NULL
the	NULL
NFAT	NULL
induction	NULL
following	NULL
treatment	NULL
with	NULL
phorbol	NULL
ester	NULL
and	NULL
calcium	NULL
ionophore	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
argue	NULL
that	NULL
the	NULL
p95	NULL
``	NULL
effect	NULL
is	NULL
specific	NULL
to	NULL
the	NULL
TCR-mediated	NULL
signaling	NULL
pathways	NULL
and	NULL
further	NULL
implicate	NULL
p95¢	NULL
``	NULL
``	NULL
function	NULL
in	NULL
the	NULL
proximal	NULL
signaling	NULL
events	NULL
upstream	NULL
of	NULL
or	NULL
parallel	NULL
to	NULL
Ras	NULL
and	NULL
calcineurin	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

An	NULL
intact	NULL
TCR	NULL
signaling	NULL
pathway	NULL
is	NULL
required	NULL
for	NULL
p95	NULL
``	NULL
to	NULL
function	NULL
.	NULL

The	NULL
earliest	NULL
events	NULL
occurring	NULL
after	NULL
TCR	NULL
stimulation	NULL
involve	NULL
the	NULL
activation	NULL
of	NULL
multiple	NULL
cytoplasmic	NULL
PTKs	NULL
,	NULL
manifested	NULL
by	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
cellular	NULL
proteins	NULL
,	NULL
including	NULL
p95¢	NULL
``	NULL
``	NULL
(	NULL
61	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
PTK	NULL
activation	NULL
is	NULL
underscored	NULL
by	NULL
the	NULL
effects	NULL
of	NULL
PTK	NULL
inhibitors	NULL
such	NULL
as	NULL
herbimycin	NULL
A	NULL
,	NULL
which	NULL
markedly	NULL
impairs	NULL
TCR	NULL
signaling	NULL
(	NULL
22	NULL
,	NULL
33	NULL
)	NULL
.	NULL

If	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
participates	NULL
in	NULL
the	NULL
TCR-mediated	NULL
signaling	NULL
pathway	NULL
,	NULL
proximal	NULL
TCR	NULL
signaling	NULL
events	NULL
may	NULL
influence	NULL
the	NULL
effect	NULL
of	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
on	NULL
NFAT	NULL
activation	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
incubation	NULL
of	NULL
p95¢	NULL
``	NULL
``	NULL
-transfected	NULL
cells	NULL
with	NULL
herbimycin	NULL
A	NULL
blocked	NULL
the	NULL
basal	NULL
activation	NULL
of	NULL
NFAT	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
PTKs	NULL
are	NULL
required	NULL
for	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
function	NULL
.	NULL

One	NULL
of	NULL
the	NULL
cytoplasmic	NULL
PTKs	NULL
required	NULL
for	NULL
proximal	NULL
TCR	NULL
signaling	NULL
is	NULL
Leck	NULL
.	NULL

A	NULL
mutant	NULL
Jurkat	NULL
cell	NULL
line	NULL
,	NULL
JCaM1.6	NULL
,	NULL
lacking	NULL
functional	NULL
Lek	NULL
fails	NULL
to	NULL
mobilize	NULL
intracellular	NULL
calcium	NULL
,	NULL
to	NULL
induce	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
or	NULL
to	NULL
express	NULL
activation	NULL
antigens	NULL
following	NULL
TCR	NULL
stimulation	NULL
(	NULL
59	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
when	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
was	NULL
p95	NULL
``	NULL
IN	NULL
TCR	NULL
SIGNALING	NULL
4341	NULL
[	NULL
]	NULL
]	NULL
vector	NULL
&	NULL
100	NULL
-	NULL
B	NULL
p9Svav	NULL
9	NULL
42	NULL
o	NULL
3	NULL
``	NULL
3	NULL
E	NULL
o	NULL
H=	NULL
=-	NULL
5g	NULL
-|-	NULL
LL	NULL
.	NULL

Z	NULL
0	NULL
Unstimulated	NULL
Anti-TCR	NULL
Carbachol	NULL
J.HM1.2.2	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Overexpression	NULL
of	NULL
p95	NULL
``	NULL
in	NULL
J.HM1.2.2	NULL
cells	NULL
specifically	NULL
augments	NULL
the	NULL
TCR-mediated	NULL
NFAT	NULL
activation	NULL
.	NULL

J.HM1.2.2	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
NFAT-Luc	NULL
and	NULL
either	NULL
the	NULL
control	NULL
vector	NULL
(	NULL
pEF-BOS	NULL
)	NULL
or	NULL
p95®	NULL
``	NULL
``	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
either	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
an	NULL
anti-TCR	NULL
MAb	NULL
(	NULL
C305	NULL
)	NULL
or	NULL
carbachol	NULL
and	NULL
assayed	NULL
for	NULL
induced	NULL
luciferase	NULL
activity	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
determined	NULL
in	NULL
either	NULL
duplicate	NULL
or	NULL
triplicate	NULL
for	NULL
cach	NULL
experimental	NULL
condition	NULL
.	NULL

The	NULL
results	NULL
are	NULL
shown	NULL
as	NULL
the	NULL
fold	NULL
induction	NULL
of	NULL
luciferase	NULL
activity	NULL
compared	NULL
with	NULL
the	NULL
activity	NULL
in	NULL
unstimulated	NULL
cells	NULL
cotransfected	NULL
with	NULL
the	NULL
empty	NULL
pEF-BOS	NULL
and	NULL
NFAT-Luc	NULL
reporter	NULL
construct	NULL
.	NULL

Luciferase	NULL
activities	NULL
of	NULL
the	NULL
unstimulated	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
pEF-BOS	NULL
vector	NULL
were	NULL
typically	NULL
500	NULL
to	NULL
1,000	NULL
AU	NULL
.	NULL

Maximal	NULL
stimulated	NULL
activities	NULL
(	NULL
by	NULL
treatment	NULL
with	NULL
50	NULL
ng	NULL
of	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
per	NULL
ml	NULL
and	NULL
1.0	NULL
wM	NULL
ionomycin	NULL
)	NULL
were	NULL
typically	NULL
about	NULL
1	NULL
x	NULL
10°	NULL
to	NULL
3	NULL
X	NULL
10°	NULL
AU	NULL
.	NULL

The	NULL
data	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

overexpressed	NULL
in	NULL
JCaM1.6	NULL
,	NULL
no	NULL
basal	NULL
induction	NULL
of	NULL
NFAT	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

Reconstitution	NULL
of	NULL
this	NULL
mutant	NULL
cell	NULL
with	NULL
wild-type	NULL
murine	NULL
Leck	NULL
restored	NULL
all	NULL
TCR-mediated	NULL
function	NULL
as	NULL
well	NULL
as	NULL
the	NULL
p95	NULL
``	NULL
effect	NULL
on	NULL
NFAT	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
and	NULL
C	NULL
)	NULL
(	NULL
59	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
v-H-ras	NULL
was	NULL
still	NULL
able	NULL
to	NULL
activate	NULL
NFAT	NULL
in	NULL
synergy	NULL
with	NULL
ionomycin	NULL
in	NULL
JCaM1.6	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
,	NULL
unlike	NULL
activated	NULL
Ras	NULL
,	NULL
requires	NULL
proximal	NULL
signals	NULL
which	NULL
depend	NULL
on	NULL
Lck	NULL
to	NULL
exert	NULL
its	NULL
activity	NULL
.	NULL

Another	NULL
Jurkat	NULL
mutant	NULL
cell	NULL
line	NULL
,	NULL
145.01	NULL
,	NULL
which	NULL
lacks	NULL
CD45	NULL
membrane	NULL
protein	NULL
tyrosine	NULL
phos-phatase	NULL
,	NULL
is	NULL
defective	NULL
in	NULL
TCR-mediated	NULL
signaling	NULL
at	NULL
a	NULL
very	NULL
proximal	NULL
step	NULL
(	NULL
41	NULL
)	NULL
.	NULL

The	NULL
block	NULL
in	NULL
J45.01	NULL
is	NULL
thought	NULL
to	NULL
result	NULL
from	NULL
negative	NULL
regulation	NULL
of	NULL
Lek	NULL
(	NULL
58	NULL
)	NULL
.	NULL

As	NULL
with	NULL
JCaM1.6	NULL
cells	NULL
,	NULL
no	NULL
NFAT	NULL
induction	NULL
was	NULL
detected	NULL
when	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
was	NULL
overexpressed	NULL
in	NULL
J45.01	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

These	NULL
data	NULL
strongly	NULL
suggest	NULL
that	NULL
a	NULL
PTK	NULL
(	NULL
Leck	NULL
)	NULL
and	NULL
a	NULL
phosphatase	NULL
(	NULL
CD45	NULL
)	NULL
,	NULL
which	NULL
are	NULL
required	NULL
for	NULL
proximal	NULL
events	NULL
in	NULL
TCR	NULL
signaling	NULL
,	NULL
are	NULL
crucial	NULL
for	NULL
p95¢	NULL
``	NULL
``	NULL
function	NULL
.	NULL

Recent	NULL
studies	NULL
showed	NULL
that	NULL
the	NULL
signaling	NULL
function	NULL
of	NULL
the	NULL
TCR	NULL
complex	NULL
reside	NULL
within	NULL
a	NULL
common	NULL
motif	NULL
(	NULL
ITAM	NULL
)	NULL
in	NULL
CD3	NULL
and	NULL
TCR	NULL
{	NULL
chains	NULL
(	NULL
30	NULL
,	NULL
55	NULL
)	NULL
.	NULL

Following	NULL
TCR	NULL
cross-linking	NULL
,	NULL
ITAMs	NULL
in	NULL
CD3	NULL
and	NULL
TCR	NULL
£	NULL
chains	NULL
become	NULL
tyrosine	NULL
phosphor-ylated	NULL
,	NULL
possibly	NULL
by	NULL
Lck	NULL
,	NULL
and	NULL
serve	NULL
as	NULL
the	NULL
binding	NULL
sites	NULL
for	NULL
another	NULL
cytoplasmic	NULL
PTK	NULL
,	NULL
ZAP-70	NULL
(	NULL
9	NULL
,	NULL
61	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
TCR	NULL
ITAMs	NULL
function	NULL
as	NULL
membrane	NULL
anchors	NULL
to	NULL
facilitate	NULL
the	NULL
interaction	NULL
of	NULL
Leck	NULL
and	NULL
ZAP-70	NULL
(	NULL
31	NULL
)	NULL
.	NULL

These	NULL
initial	NULL
biochemical	NULL
events	NULL
then	NULL
lead	NULL
to	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
downstream	NULL
intracellular	NULL
substrates	NULL
.	NULL

The	NULL
potential	NULL
involvement	NULL
of	NULL
p95¢	NULL
``	NULL
``	NULL
in	NULL
the	NULL
initial	NULL
events	NULL
in	NULL
TCR-mediated	NULL
signaling	NULL
pathways	NULL
was	NULL
further	NULL
demonstrated	NULL
by	NULL
using	NULL
a	NULL
mutant	NULL
Jurkat	NULL
cell	NULL
line	NULL
,	NULL
J.RT3-T3.5	NULL
,	NULL
which	NULL
fails	NULL
to	NULL
express	NULL
a	NULL
TCR	NULL
because	NULL
of	NULL
TCR	NULL
B-chain	NULL
deficiency	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
p95¢	NULL
``	NULL
``	NULL
in	NULL
J.RT3-T3.5	NULL
cells	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
basal	NULL
NFAT	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Another	NULL
4342	NULL
,	NULL
WU	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

A	NULL
B	NULL
s0	NULL
40	NULL
[	NULL
]	NULL
vector	NULL
c	NULL
R	NULL
p9S5vav	NULL
o	NULL
5	NULL
z	NULL
2	NULL
o	NULL
8	NULL
0	NULL
so-	NULL
3	NULL
3	NULL
C	NULL
3	NULL
£	NULL
E	NULL
S	NULL
3	NULL
20	NULL
-	NULL
i2	NULL
H	NULL
i-|_	NULL
<	NULL
m	NULL
-	NULL
10	NULL
{	NULL
2	NULL
o	NULL
._	NULL
Cy	NULL
-	NULL
-	NULL
herbimycin	NULL
+-	NULL
herbimycin	NULL
JCaM1.6	NULL
445.01	NULL
JCaM1.6/Lck	NULL
-	NULL
Jurkat	NULL
Treatment	NULL
Cell	NULL
line	NULL
C	NULL
D	NULL
400	NULL
wor	NULL
venues	NULL
cument	NULL
P	NULL
<	NULL
4~	NULL
LJ	NULL
vector	NULL
V	NULL
©	NULL
p9Svav	NULL
/	NULL
1	NULL
2	NULL
3	NULL
A	NULL
&	NULL
-	NULL
3007	NULL
FAM	NULL
v-H-ras	NULL
/	NULL
3	NULL
/	NULL
U	NULL
=	NULL
]	NULL
E	NULL
P	NULL
€	NULL
/	NULL
B	NULL
-	NULL
200	NULL
-	NULL
/	NULL
6	NULL
LL	NULL
/	NULL
<	NULL
%	NULL
LL	NULL
Z	NULL
/	NULL
100	NULL
-	NULL
%	NULL
o	NULL
.	NULL

Unstimulated	NULL
lonomycin	NULL
Anti-	NULL
TCR	NULL
JCaM1.6	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
overexpression	NULL
on	NULL
NFAT	NULL
activation	NULL
requires	NULL
the	NULL
proximal	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
NFAT	NULL
induction	NULL
by	NULL
overexpressing	NULL
p95	NULL
``	NULL
is	NULL
sensitive	NULL
to	NULL
herbimycin	NULL
A	NULL
treatment	NULL
.	NULL

TAg	NULL
Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
NFAT-Luc	NULL
and	NULL
either	NULL
an	NULL
empty	NULL
vector	NULL
(	NULL
pSV7d	NULL
)	NULL
or	NULL
p95®*	NULL
``	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
either	NULL
untreated	NULL
or	NULL
treated	NULL
with	NULL
herbimycin	NULL
A	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
showed	NULL
that	NULL
herbimycin	NULL
A	NULL
treatment	NULL
does	NULL
not	NULL
inhibit	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
overexpression	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Overexpression	NULL
of	NULL
p95	NULL
``	NULL
in	NULL
Jurkat	NULL
mutants	NULL
deficient	NULL
in	NULL
TCR	NULL
signaling	NULL
does	NULL
not	NULL
lead	NULL
to	NULL
basal	NULL
NFAT	NULL
activation	NULL
.	NULL

JCaM1.6	NULL
,	NULL
145.01	NULL
,	NULL
Lek-reconstituted	NULL
JCaM1.6	NULL
(	NULL
JCaM1.6/Lck	NULL
)	NULL
,	NULL
and	NULL
wild-type	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
NFAT	NULL
-Luc	NULL
and	NULL
either	NULL
an	NULL
empty	NULL
vector	NULL
or	NULL
mye-p95¢	NULL
``	NULL
.	NULL

Unstimulated	NULL
cells	NULL
were	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Anti-myc	NULL
epitope	NULL
blot	NULL
of	NULL
equivalent	NULL
amount	NULL
of	NULL
lysates	NULL
from	NULL
different	NULL
transfectants	NULL
in	NULL
panel	NULL
B	NULL
.	NULL

Lanes	NULL
1	NULL
through	NULL
4	NULL
represent	NULL
lysates	NULL
from	NULL
transfected	NULL
JCaM1.6	NULL
,	NULL
J45.01	NULL
,	NULL
JCaM1.6/Lck	NULL
,	NULL
and	NULL
Jurkat	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
D	NULL
)	NULL
v-H-ras	NULL
,	NULL
but	NULL
not	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
,	NULL
functions	NULL
in	NULL
a	NULL
Lek-deficient	NULL
Jurkat	NULL
mutant	NULL
.	NULL

JCaM1.6	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
NFAT-Luc	NULL
along	NULL
with	NULL
either	NULL
an	NULL
empty	NULL
vector	NULL
,	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
,	NULL
or	NULL
v-H-ras	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
either	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
ionomycin	NULL
or	NULL
an	NULL
anti-TCR	NULL
MAb	NULL
(	NULL
C305	NULL
)	NULL
and	NULL
subsequently	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

The	NULL
results	NULL
are	NULL
shown	NULL
as	NULL
the	NULL
fold	NULL
induction	NULL
over	NULL
that	NULL
in	NULL
untreated	NULL
(	NULL
A	NULL
)	NULL
or	NULL
unstimulated	NULL
(	NULL
B	NULL
and	NULL
D	NULL
)	NULL
vector-transfected	NULL
cells	NULL
.	NULL

The	NULL
data	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

HM1R-expressing	NULL
TCR-negative	NULL
Jurkat	NULL
cell	NULL
line	NULL
,	NULL
J.HM1.2.1	NULL
,	NULL
also	NULL
failed	NULL
to	NULL
induce	NULL
NFAT	NULL
when	NULL
p95¢	NULL
``	NULL
``	NULL
was	NULL
overexpressed	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

The	NULL
p95¢*	NULL
``	NULL
-induced	NULL
NFAT	NULL
activation	NULL
was	NULL
restored	NULL
in	NULL
two	NULL
of	NULL
the	NULL
TCR-	NULL
reconstituted	NULL
Jurkat	NULL
cells	NULL
lines	NULL
,	NULL
PF-2.8	NULL
and	NULL
PF-2.4	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
intermediate	NULL
effect	NULL
on	NULL
NFAT	NULL
activity	NULL
in	NULL
PF2.8	NULL
cells	NULL
may	NULL
reflect	NULL
the	NULL
fact	NULL
that	NULL
this	NULL
cell	NULL
expresses	NULL
only	NULL
15	NULL
%	NULL
of	NULL
the	NULL
level	NULL
of	NULL
TCR	NULL
expressed	NULL
by	NULL
Jurkat	NULL
cells	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Figure	NULL
5B	NULL
shows	NULL
that	NULL
p95¢	NULL
``	NULL
``	NULL
was	NULL
comparably	NULL
overexpressed	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
J.HM1.2.1	NULL
and	NULL
Jurkat	NULL
cells	NULL
overexpressed	NULL
similar	NULL
levels	NULL
of	NULL
p95¢	NULL
``	NULL
``	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
a	NULL
functional	NULL
TCR	NULL
is	NULL
required	NULL
for	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
to	NULL
function	NULL
.	NULL

The	NULL
proximal	NULL
TCR	NULL
signaling	NULL
events	NULL
do	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
altered	NULL
in	NULL
the	NULL
p95	NULL
``	NULL
-overexpressing	NULL
cells	NULL
.	NULL

The	NULL
data	NULL
above	NULL
suggest	NULL
that	NULL
p95¢	NULL
``	NULL
``	NULL
may	NULL
participate	NULL
in	NULL
the	NULL
proximal	NULL
events	NULL
in	NULL
TCR-mediated	NULL
signal	NULL
transduction	NULL
.	NULL

One	NULL
hypothesis	NULL
is	NULL
that	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
normally	NULL
acts	NULL
as	NULL
a	NULL
positive	NULL
regulator	NULL
or	NULL
interacts	NULL
with	NULL
negative	NULL
regulators	NULL
for	NULL
a	NULL
proximal	NULL
PTK	NULL
,	NULL
Lck	NULL
or	NULL
ZAP-70	NULL
,	NULL
involved	NULL
in	NULL
TCR	NULL
signaling	NULL
.	NULL

Therefore	NULL
one	NULL
might	NULL
expect	NULL
that	NULL
overexpression	NULL
of	NULL
p95¢	NULL
``	NULL
``	NULL
may	NULL
activate	NULL
these	NULL
PTKs	NULL
,	NULL
resulting	NULL
in	NULL
hyperphos-phorylation	NULL
of	NULL
the	NULL
downstream	NULL
substrates	NULL
,	NULL
and	NULL
lead	NULL
to	NULL
NFAT	NULL
activation	NULL
.	NULL

To	NULL
study	NULL
whether	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
overexpression	NULL
increases	NULL
the	NULL
levels	NULL
of	NULL
cellular	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
we	NULL
cotransfected	NULL
truncated	NULL
CD8	NULL
,	NULL
using	NULL
it	NULL
as	NULL
a	NULL
surface	NULL
marker	NULL
to	NULL
purify	NULL
the	NULL
p95	NULL
``	NULL
-transfected	NULL
cells	NULL
by	NULL
using	NULL
magnetic	NULL
beads	NULL
,	NULL
and	NULL
analyzed	NULL
the	NULL
unstimulated	NULL
and	NULL
TCR-stimulated	NULL
cell	NULL
lysates	NULL
.	NULL

We	NULL
have	NULL
found	NULL
that	NULL
when	NULL
two	NULL
plasmid	NULL
constructs	NULL
are	NULL
used	NULL
in	NULL
such	NULL
co-transfections	NULL
,	NULL
the	NULL
plasmids	NULL
are	NULL
taken	NULL
up	NULL
and	NULL
expressed	NULL
by	NULL
the	NULL
same	NULL
population	NULL
of	NULL
cells	NULL
.	NULL

Similar	NULL
approaches	NULL
have	NULL
also	NULL
been	NULL
used	NULL
by	NULL
others	NULL
(	NULL
4	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
we	NULL
found	NULL
no	NULL
significant	NULL
alteration	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
unstimulated	NULL
or	NULL
stim-	NULL
Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
A	NULL
40	NULL
£	NULL
2	NULL
G	NULL
3	NULL
C	NULL
£	NULL
C	NULL
o	NULL
L.	NULL
|=	NULL
<	NULL
L_	NULL
.	NULL

Z	NULL
Jurkat	NULL
-	NULL
J.RT3-T3.5	NULL
J.HM1.2.1	NULL
_	NULL
PF-2.8	NULL
PF-2.4	NULL
Cell	NULL
line	NULL
B	NULL
«	NULL
--	NULL
-	NULL
.	NULL

@	NULL
aem	NULL
gmme	NULL
were	NULL
|	NULL
*+	NULL
1	NULL
2	NULL
3	NULL
4	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Expression	NULL
of	NULL
a	NULL
TCR	NULL
is	NULL
required	NULL
for	NULL
p95	NULL
``	NULL
function	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Wild-type	NULL
Jurkat	NULL
,	NULL
J.RT3-T3.5	NULL
,	NULL
J.HM1.2.1	NULL
,	NULL
PF-2.8	NULL
,	NULL
and	NULL
PF-2.4	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
NFAT-Luc	NULL
and	NULL
either	NULL
an	NULL
empty	NULL
vector	NULL
(	NULL
pEF-BOS	NULL
)	NULL
or	NULL
myc-p95	NULL
``	NULL
``	NULL
``	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
assayed	NULL
for	NULL
basal	NULL
luciferase	NULL
activity	NULL
.	NULL

The	NULL
results	NULL
are	NULL
shown	NULL
as	NULL
the	NULL
fold	NULL
induction	NULL
over	NULL
that	NULL
in	NULL
unstimulated	NULL
vector-transfected	NULL
cells	NULL
.	NULL

The	NULL
data	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Anti-mye	NULL
blot	NULL
of	NULL
lysates	NULL
from	NULL
p95	NULL
``	NULL
-transfected	NULL
Jurkat	NULL
,	NULL
J.RT3-T3.5	NULL
,	NULL
PF-2.8	NULL
,	NULL
and	NULL
PF-2.4	NULL
cells	NULL
(	NULL
lanes	NULL
1	NULL
through	NULL
4	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

p95	NULL
``	NULL
was	NULL
also	NULL
overexpressed	NULL
in	NULL
J.HML2.1	NULL
cells	NULL
to	NULL
a	NULL
level	NULL
similar	NULL
to	NULL
that	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

ulated	NULL
p95¢	NULL
``	NULL
``	NULL
-overexpressing	NULL
cells	NULL
compared	NULL
with	NULL
control	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
balance	NULL
between	NULL
the	NULL
proximal	NULL
PTKs	NULL
and	NULL
protein	NULL
tyrosine	NULL
phosphatases	NULL
is	NULL
largely	NULL
unaltered	NULL
by	NULL
p95¢	NULL
``	NULL
``	NULL
overexpression	NULL
.	NULL

TCR	NULL
stimulation	NULL
activates	NULL
PLC-y1	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
sustained	NULL
rise	NULL
of	NULL
intracellular	NULL
calcium	NULL
.	NULL

If	NULL
p95¢	NULL
``	NULL
``	NULL
potentiates	NULL
the	NULL
proximal	NULL
TCR	NULL
signaling	NULL
events	NULL
,	NULL
this	NULL
calcium	NULL
response	NULL
may	NULL
be	NULL
modulated	NULL
in	NULL
the	NULL
p95	NULL
``	NULL
``	NULL
-overexpressing	NULL
cells	NULL
.	NULL

TAg	NULL
Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
truncated	NULL
CD8	NULL
and	NULL
p95¢	NULL
``	NULL
``	NULL
.	NULL

We	NULL
analyzed	NULL
the	NULL
TCR	NULL
Stimulation	NULL
-	NULL
+	NULL
-	NULL
+	NULL
106	NULL
80	NULL
#	NULL
1	NULL
«	NULL
1	NULL
49.5	NULL
32.5-1	NULL
2	NULL
3	NULL
4	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Basal	NULL
and	NULL
TCR-stimulated	NULL
cellular	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
p95	NULL
``	NULL
``	NULL
-overexpressing	NULL
Jurkat	NULL
cells	NULL
.	NULL

TAg	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
truncated	NULL
CD8	NULL
along	NULL
with	NULL
either	NULL
pSV7d	NULL
vector	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
p95	NULL
``	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
CD8-expressing	NULL
cells	NULL
were	NULL
purified	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
and	NULL
either	NULL
left	NULL
unstimulated	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
an	NULL
anti-TCR	NULL
MAb	NULL
(	NULL
C305	NULL
)	NULL
for	NULL
2	NULL
min	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Whole	NULL
cell	NULL
lysates	NULL
were	NULL
prepared	NULL
and	NULL
blotted	NULL
with	NULL
antiphosphotyrosine	NULL
MAb	NULL
4G10	NULL
.	NULL

p95	NULL
``	NULL
IN	NULL
TCR	NULL
SIGNALING	NULL
4343	NULL
intracellular	NULL
calcium	NULL
levels	NULL
in	NULL
CD8*	NULL
and	NULL
CD8~	NULL
cells	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

The	NULL
gated	NULL
CD8-positive	NULL
transfectants	NULL
overexpressed	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
as	NULL
determined	NULL
by	NULL
Western	NULL
blotting	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7A	NULL
and	NULL
B	NULL
,	NULL
there	NULL
is	NULL
no	NULL
significant	NULL
difference	NULL
in	NULL
either	NULL
the	NULL
basal	NULL
or	NULL
TCR-stimulated	NULL
level	NULL
of	NULL
intracellular	NULL
calcium	NULL
in	NULL
p95¢	NULL
``	NULL
``	NULL
-overexpressing	NULL
cells	NULL
compared	NULL
with	NULL
nontransfected	NULL
cells	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
overexpression	NULL
of	NULL
p95¢	NULL
``	NULL
``	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
does	NULL
not	NULL
activate	NULL
the	NULL
proximal	NULL
PTKs	NULL
involved	NULL
in	NULL
TCR	NULL
signaling	NULL
.	NULL

DISCUSSION	NULL
Signaling	NULL
through	NULL
the	NULL
TCR	NULL
results	NULL
in	NULL
a	NULL
rapid	NULL
increase	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
numerous	NULL
intracellular	NULL
proteins	NULL
,	NULL
including	NULL
the	NULL
proto-oncogene	NULL
product	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
,	NULL
and	NULL
ultimately	NULL
leads	NULL
to	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
(	NULL
61	NULL
)	NULL
.	NULL

The	NULL
detailed	NULL
molecular	NULL
mechanism	NULL
by	NULL
which	NULL
the	NULL
biochemical	NULL
events	NULL
initiated	NULL
by	NULL
the	NULL
TCR	NULL
on	NULL
the	NULL
plasma	NULL
membrane	NULL
are	NULL
transmitted	NULL
to	NULL
the	NULL
nucleus	NULL
is	NULL
still	NULL
poorly	NULL
understood	NULL
.	NULL

However	NULL
,	NULL
the	NULL
induced	NULL
tyrosine	NULL
phosphoproteins	NULL
are	NULL
likely	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
show	NULL
that	NULL
overexpression	NULL
of	NULL
p95¢	NULL
``	NULL
``	NULL
,	NULL
one	NULL
of	NULL
these	NULL
substrates	NULL
,	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
leads	NULL
to	NULL
a	NULL
marked	NULL
induction	NULL
of	NULL
the	NULL
basal	NULL
and	NULL
TCR-mediated	NULL
IL-2	NULL
promoter	NULL
activity	NULL
.	NULL

Furthermore	NULL
,	NULL
this	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
activity	NULL
requires	NULL
the	NULL
functions	NULL
of	NULL
both	NULL
Ras	NULL
and	NULL
calcineurin	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
functional	NULL
TCR	NULL
complex	NULL
.	NULL

Our	NULL
data	NULL
strongly	NULL
implicate	NULL
the	NULL
involvement	NULL
of	NULL
p95¢	NULL
``	NULL
``	NULL
in	NULL
the	NULL
TCR-mediated	NULL
signaling	NULL
pathway	NULL
.	NULL

This	NULL
finding	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
impaired	NULL
function	NULL
of	NULL
antigen	NULL
receptors	NULL
on	NULL
T	NULL
and	NULL
B	NULL
lymphocytes	NULL
which	NULL
fail	NULL
to	NULL
express	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
(	NULL
16a	NULL
,	NULL
60	NULL
,	NULL
64	NULL
)	NULL
.	NULL

It	NULL
is	NULL
striking	NULL
that	NULL
an	NULL
intact	NULL
N-terminal	NULL
region	NULL
is	NULL
required	NULL
for	NULL
p95¢	NULL
``	NULL
``	NULL
to	NULL
exert	NULL
its	NULL
activity	NULL
on	NULL
NFAT	NULL
.	NULL

Although	NULL
overexpression	NULL
of	NULL
the	NULL
full-length	NULL
vay	NULL
may	NULL
nonspecifically	NULL
titrate	NULL
out	NULL
a	NULL
negative	NULL
inhibitor	NULL
of	NULL
TCR	NULL
signaling	NULL
pathways	NULL
,	NULL
this	NULL
is	NULL
unlikely	NULL
since	NULL
overexpression	NULL
of	NULL
the	NULL
N-terminal	NULL
region	NULL
alone	NULL
or	NULL
a	NULL
truncated	NULL
form	NULL
of	NULL
p95	NULL
``	NULL
lacking	NULL
its	NULL
C-terminal	NULL
Sre	NULL
homology	NULL
domains	NULL
fails	NULL
to	NULL
mimic	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
full-length	NULL
p95	NULL
``	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
leucine-rich	NULL
amino-terminal	NULL
of	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
was	NULL
initially	NULL
reported	NULL
to	NULL
contain	NULL
a	NULL
helix-loop-helix	NULL
domain	NULL
followed	NULL
by	NULL
a	NULL
leucine	NULL
zipper	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
carboxy-terminal	NULL
region	NULL
of	NULL
myc	NULL
proteins	NULL
and	NULL
the	NULL
steroid	NULL
binding	NULL
domains	NULL
of	NULL
nuclear	NULL
receptors	NULL
(	NULL
11	NULL
,	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

However	NULL
,	NULL
when	NULL
more	NULL
objective	NULL
and	NULL
quantitative	NULL
criteria	NULL
were	NULL
applied	NULL
in	NULL
the	NULL
sequence	NULL
comparison	NULL
,	NULL
none	NULL
of	NULL
these	NULL
similarities	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
significant	NULL
(	NULL
1	NULL
,	NULL
3	NULL
)	NULL
.	NULL

None-theless	NULL
,	NULL
removal	NULL
of	NULL
this	NULL
region	NULL
can	NULL
activate	NULL
p95¢	NULL
``	NULL
``	NULL
transforming	NULL
potential	NULL
in	NULL
NIH	NULL
3T3	NULL
cells	NULL
,	NULL
suggesting	NULL
a	NULL
regulatory	NULL
function	NULL
of	NULL
the	NULL
N-terminal	NULL
region	NULL
(	NULL
11	NULL
,	NULL
34	NULL
)	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
that	NULL
this	NULL
region	NULL
has	NULL
some	NULL
similarity	NULL
with	NULL
molecules	NULL
which	NULL
interact	NULL
with	NULL
actin	NULL
or	NULL
other	NULL
cytoskeletal	NULL
proteins	NULL
(	NULL
1	NULL
)	NULL
.	NULL

One	NULL
possibility	NULL
is	NULL
that	NULL
the	NULL
N-terminal	NULL
region	NULL
allows	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
to	NULL
bind	NULL
to	NULL
certain	NULL
cytoskeletal	NULL
components	NULL
,	NULL
and	NULL
deletion	NULL
of	NULL
this	NULL
region	NULL
may	NULL
release	NULL
p95¢	NULL
``	NULL
``	NULL
to	NULL
interact	NULL
with	NULL
other	NULL
signaling	NULL
processes	NULL
and	NULL
cause	NULL
transforma-tion	NULL
.	NULL

However	NULL
,	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
this	NULL
region	NULL
appears	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
p95	NULL
``	NULL
function	NULL
,	NULL
perhaps	NULL
by	NULL
anchoring	NULL
it	NULL
to	NULL
an	NULL
appropriate	NULL
compartment	NULL
to	NULL
exert	NULL
its	NULL
physiological	NULL
function	NULL
.	NULL

The	NULL
identification	NULL
of	NULL
molecules	NULL
that	NULL
interact	NULL
with	NULL
this	NULL
region	NULL
will	NULL
be	NULL
informative	NULL
to	NULL
understand	NULL
its	NULL
function	NULL
.	NULL

p95	NULL
``	NULL
shares	NULL
homology	NULL
with	NULL
proven	NULL
or	NULL
putative	NULL
Rho/Rac	NULL
GEF	NULL
domains	NULL
found	NULL
in	NULL
yeast	NULL
CDC24	NULL
,	NULL
rodent	NULL
CDC25Y	NULL
,	NULL
and	NULL
human	NULL
Dbl	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Unfortunately	NULL
,	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
functions	NULL
of	NULL
these	NULL
GEFs	NULL
,	NULL
largely	NULL
because	NULL
of	NULL
the	NULL
difficulties	NULL
in	NULL
demonstrating	NULL
their	NULL
catalytic	NULL
activities	NULL
against	NULL
Rho	NULL
or	NULL
Rac	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
only	NULL
two	NULL
members	NULL
of	NULL
this	NULL
group	NULL
,	NULL
CDC24	NULL
and	NULL
Dbl	NULL
,	NULL
have	NULL
recently	NULL
been	NULL
demonstrated	NULL
to	NULL
activate	NULL
Rho	NULL
or	NULL
Rac	NULL
GTPase	NULL
activity	NULL
in	NULL
vitro	NULL
(	NULL
2	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
p95¢	NULL
``	NULL
``	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
antigen	NULL
receptor-stimulated	NULL
Ras	NULL
activation	NULL
in	NULL
lymphocytes	NULL
(	NULL
23	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
show	NULL
that	NULL
the	NULL
4344	NULL
WU	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
B	NULL
104	NULL
a	NULL
24	NULL
%	NULL
8	NULL
1094	NULL
Cbs+	NULL
£	NULL
©	NULL
®	NULL
3	NULL
o	NULL
§	NULL
Cane	NULL
©	NULL
é	NULL
10	NULL
CC	NULL
6	NULL
70	NULL
%	NULL
CD8~	NULL
``	NULL
101A	NULL
10°	NULL
o	NULL
_	NULL
200	NULL
400	NULL
-	NULL
600	NULL
_	NULL
300	NULL
_	NULL
1000	NULL
Mean	NULL
ratio	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Relative	NULL
number	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Intracellular	NULL
calcium	NULL
level	NULL
in	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
-overexpressing	NULL
Jurkat	NULL
cells	NULL
.	NULL

TAg	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
truncated	NULL
CD8	NULL
and	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
FITC-CD8	NULL
Ab	NULL
and	NULL
loaded	NULL
with	NULL
Indo-1	NULL
as	NULL
described	NULL
in	NULL
the	NULL
text	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
top	NULL
25	NULL
%	NULL
of	NULL
the	NULL
transfected	NULL
cells	NULL
(	NULL
the	NULL
CDS-positive	NULL
cells	NULL
)	NULL
contain	NULL
the	NULL
p95	NULL
``	NULL
``	NULL
-overexpressing	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
horizontal	NULL
axis	NULL
shows	NULL
the	NULL
Indo-1	NULL
fluorescence	NULL
ratio	NULL
representing	NULL
the	NULL
intracellular	NULL
calcium	NULL
level	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Transfected	NULL
cells	NULL
were	NULL
gated	NULL
as	NULL
in	NULL
panel	NULL
A	NULL
and	NULL
were	NULL
either	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
an	NULL
anti-TCR	NULL
MAb	NULL
(	NULL
C305	NULL
)	NULL
for	NULL
60	NULL
,	NULL
120	NULL
,	NULL
180	NULL
,	NULL
240	NULL
s.	NULL
The	NULL
left	NULL
and	NULL
right	NULL
panels	NULL
shows	NULL
the	NULL
calcium	NULL
levels	NULL
in	NULL
gated	NULL
CD8-positive	NULL
and	NULL
CD8-negative	NULL
populations	NULL
,	NULL
respectively	NULL
.	NULL

effect	NULL
of	NULL
p95¢	NULL
``	NULL
``	NULL
overexpression	NULL
is	NULL
distinct	NULL
from	NULL
that	NULL
of	NULL
simply	NULL
activating	NULL
Ras	NULL
pathway	NULL
alone	NULL
.	NULL

Moreover	NULL
,	NULL
overexpression	NULL
of	NULL
another	NULL
known	NULL
Ras	NULL
GEF	NULL
,	NULL
SCD25	NULL
,	NULL
failed	NULL
to	NULL
induce	NULL
NFAT	NULL
activation	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
reports	NULL
arguing	NULL
against	NULL
p95	NULL
``	NULL
as	NULL
a	NULL
GEF	NULL
for	NULL
Ras	NULL
(	NULL
7	NULL
,	NULL
38	NULL
)	NULL
.	NULL

The	NULL
exchange	NULL
activity	NULL
of	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
is	NULL
further	NULL
complicated	NULL
by	NULL
the	NULL
presence	NULL
in	NULL
T	NULL
cells	NULL
of	NULL
SOS	NULL
,	NULL
a	NULL
highly	NULL
conserved	NULL
Ras	NULL
GEF	NULL
in	NULL
other	NULL
signaling	NULL
processes	NULL
(	NULL
56	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
upon	NULL
TCR	NULL
ligation	NULL
,	NULL
a	NULL
36-kDa	NULL
protein	NULL
(	NULL
pp36	NULL
)	NULL
and	NULL
She	NULL
become	NULL
tyrosine	NULL
phosphorylated	NULL
and	NULL
associate	NULL
with	NULL
Grb2	NULL
,	NULL
an	NULL
adapter	NULL
protein	NULL
for	NULL
SOS	NULL
(	NULL
56	NULL
,	NULL
57	NULL
)	NULL
.	NULL

In	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
pp36-Grb2-SOS	NULL
or	NULL
a	NULL
Shc-Grb2-SOS	NULL
complex	NULL
,	NULL
rather	NULL
than	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
,	NULL
may	NULL
serve	NULL
as	NULL
the	NULL
link	NULL
between	NULL
the	NULL
receptor	NULL
and	NULL
the	NULL
downstream	NULL
Ras	NULL
pathway	NULL
(	NULL
50	NULL
,	NULL
57	NULL
)	NULL
.	NULL

How	NULL
does	NULL
overexpression	NULL
of	NULL
p95	NULL
``	NULL
lead	NULL
to	NULL
basal	NULL
activation	NULL
of	NULL
NFAT	NULL
and	NULL
further	NULL
synergy	NULL
with	NULL
TCR	NULL
stimulation	NULL
?	NULL

It	NULL
is	NULL
believed	NULL
that	NULL
the	NULL
basal	NULL
state	NULL
of	NULL
the	NULL
TCR	NULL
signaling	NULL
represents	NULL
a	NULL
dynamic	NULL
equilibrium	NULL
between	NULL
activating	NULL
and	NULL
inhibitory	NULL
signals	NULL
and	NULL
that	NULL
stimulation	NULL
through	NULL
the	NULL
TCR	NULL
leads	NULL
to	NULL
an	NULL
alteration	NULL
of	NULL
this	NULL
balance	NULL
.	NULL

One	NULL
explanation	NULL
is	NULL
that	NULL
p95	NULL
``	NULL
normally	NULL
interacts	NULL
with	NULL
a	NULL
negative	NULL
regulatory	NULL
protein	NULL
involved	NULL
in	NULL
the	NULL
proximal	NULL
TCR	NULL
signaling	NULL
pathway	NULL
.	NULL

Overexpression	NULL
of	NULL
p95¢	NULL
``	NULL
``	NULL
would	NULL
titrate	NULL
out	NULL
this	NULL
inhibitory	NULL
molecule	NULL
and	NULL
shift	NULL
the	NULL
equilibrium	NULL
to	NULL
favor	NULL
activating	NULL
signals	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
in	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
,	NULL
p95	NULL
``	NULL
is	NULL
able	NULL
to	NULL
interact	NULL
with	NULL
a	NULL
number	NULL
of	NULL
proteins	NULL
,	NULL
including	NULL
some	NULL
of	NULL
the	NULL
proximal	NULL
PTKs	NULL
(	NULL
8	NULL
,	NULL
27	NULL
,	NULL
29	NULL
,	NULL
36	NULL
)	NULL
.	NULL

However	NULL
,	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
activate	NULL
the	NULL
proximal	NULL
PTKs	NULL
,	NULL
since	NULL
we	NULL
found	NULL
no	NULL
induction	NULL
of	NULL
basal	NULL
or	NULL
TCR-stimulated	NULL
tyrosine	NULL
phosphorylation	NULL
when	NULL
analyzing	NULL
the	NULL
lysates	NULL
from	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
-overexpressing	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
our	NULL
data	NULL
on	NULL
the	NULL
intracellular	NULL
calcium	NULL
levels	NULL
in	NULL
those	NULL
cells	NULL
also	NULL
indicate	NULL
that	NULL
some	NULL
of	NULL
the	NULL
known	NULL
proximal	NULL
events	NULL
may	NULL
not	NULL
be	NULL
altered	NULL
by	NULL
p95¢	NULL
``	NULL
``	NULL
overexpression	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
phosphotyrosine	NULL
assay	NULL
is	NULL
not	NULL
sensitive	NULL
enough	NULL
,	NULL
especially	NULL
if	NULL
p95¢	NULL
``	NULL
``	NULL
modulates	NULL
only	NULL
a	NULL
subset	NULL
of	NULL
phos-phoproteins	NULL
.	NULL

Also	NULL
,	NULL
since	NULL
we	NULL
only	NULL
examined	NULL
the	NULL
cells	NULL
1	NULL
day	NULL
after	NULL
transfection	NULL
,	NULL
a	NULL
shift	NULL
of	NULL
equilibrium	NULL
by	NULL
p95	NULL
``	NULL
``	NULL
``	NULL
overexpression	NULL
may	NULL
already	NULL
be	NULL
compensated	NULL
for	NULL
.	NULL

More	NULL
detailed	NULL
kinetic	NULL
and	NULL
biochemical	NULL
analyses	NULL
will	NULL
be	NULL
important	NULL
in	NULL
assessing	NULL
p95¢	NULL
``	NULL
``	NULL
function	NULL
.	NULL

An	NULL
alternative	NULL
explanation	NULL
is	NULL
that	NULL
p95¢	NULL
``	NULL
``	NULL
may	NULL
be	NULL
a	NULL
key	NULL
limiting	NULL
mediator	NULL
in	NULL
the	NULL
TCR-mediated	NULL
signaling	NULL
cascade	NULL
.	NULL

Overexpression	NULL
of	NULL
p95¢	NULL
``	NULL
``	NULL
may	NULL
amplify	NULL
the	NULL
basal	NULL
TCR	NULL
signaling	NULL
and	NULL
allow	NULL
it	NULL
to	NULL
proceed	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
the	NULL
requirement	NULL
for	NULL
Lek	NULL
or	NULL
TCR	NULL
expression	NULL
could	NULL
reflect	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
p95	NULL
``	NULL
in	NULL
order	NULL
to	NULL
exhibit	NULL
its	NULL
functional	NULL
activity	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
in	NULL
p95¢	NULL
``	NULL
``	NULL
-overexpressing	NULL
Jurkat	NULL
cells	NULL
,	NULL
p95¢	NULL
``	NULL
``	NULL
was	NULL
weakly	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
the	NULL
basal	NULL
state	NULL
,	NULL
and	NULL
its	NULL
tyrosine	NULL
phosphorylation	NULL
was	NULL
further	NULL
induced	NULL
upon	NULL
stimulation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
that	NULL
not	NULL
only	NULL
do	NULL
p95¢	NULL
``	NULL
``	NULL
and	NULL
Dbl	NULL
contain	NULL
similar	NULL
GEF	NULL
regions	NULL
for	NULL
Rho	NULL
,	NULL
but	NULL
their	NULL
oncogenic	NULL
forms	NULL
also	NULL
share	NULL
the	NULL
same	NULL
transforming	NULL
phenotypes	NULL
in	NULL
NIH	NULL
3T3	NULL
cells	NULL
(	NULL
1	NULL
,	NULL
7	NULL
,	NULL
38	NULL
)	NULL
.	NULL

Since	NULL
Dbl	NULL
has	NULL
been	NULL
recently	NULL
shown	NULL
to	NULL
activate	NULL
Rho	NULL
and	NULL
Rac	NULL
but	NULL
not	NULL
Ras	NULL
(	NULL
28	NULL
)	NULL
,	NULL
p95¢	NULL
``	NULL
``	NULL
may	NULL
act	NULL
as	NULL
a	NULL
Rho/Rac	NULL
GEF	NULL
in	NULL
hematopoictic	NULL
cells	NULL
.	NULL

One	NULL
of	NULL
the	NULL
earliest	NULL
responses	NULL
of	NULL
cells	NULL
to	NULL
many	NULL
extracellular	NULL
factors	NULL
is	NULL
a	NULL
rapid	NULL
reorganization	NULL
of	NULL
their	NULL
actin	NULL
cytoskeleton	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
formation	NULL
of	NULL
stress	NULL
fibers	NULL
and	NULL
focal	NULL
adhesions	NULL
is	NULL
dependent	NULL
on	NULL
Rho	NULL
proteins	NULL
(	NULL
53	NULL
)	NULL
,	NULL
whereas	NULL
membrane	NULL
ruffling	NULL
requires	NULL
Rac	NULL
proteins	NULL
(	NULL
54	NULL
)	NULL
.	NULL

Rho	NULL
and	NULL
Rac	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
regulating	NULL
degranulation	NULL
in	NULL
mast	NULL
cells	NULL
(	NULL
49	NULL
)	NULL
.	NULL

In	NULL
cytotoxic	NULL
T	NULL
cells	NULL
,	NULL
TCR	NULL
stimulation	NULL
triggers	NULL
a	NULL
massive	NULL
and	NULL
rapid	NULL
cytoskeleton	NULL
rearrangement	NULL
.	NULL

Moreover	NULL
,	NULL
expression	NULL
of	NULL
RacZ2	NULL
,	NULL
a	NULL
hematopoietic	NULL
cell-specific	NULL
Rac	NULL
family	NULL
member	NULL
,	NULL
is	NULL
up-regulated	NULL
upon	NULL
T-cell	NULL
activation	NULL
(	NULL
52	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
p95	NULL
``	NULL
``	NULL
-mediated	NULL
activation	NULL
of	NULL
Rho	NULL
and/or	NULL
Rac	NULL
may	NULL
be	NULL
an	NULL
important	NULL
TCR-mediated	NULL
signaling	NULL
event	NULL
,	NULL
in	NULL
combination	NULL
with	NULL
the	NULL
Ras	NULL
and	NULL
calcineurin	NULL
signals	NULL
,	NULL
leading	NULL
to	NULL
downstream	NULL
effector	NULL
functions	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
recent	NULL
evidence	NULL
suggest	NULL
that	NULL
vay	NULL
and	NULL
Ras	NULL
may	NULL
mediate	NULL
distinct	NULL
but	NULL
interactive	NULL
signaling	NULL
pathways	NULL
in	NULL
fibroblasts	NULL
(	NULL
7	NULL
,	NULL
35	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
p95¢	NULL
``	NULL
``	NULL
in	NULL
T	NULL
cells	NULL
may	NULL
lead	NULL
to	NULL
activation	NULL
of	NULL
these	NULL
small	NULL
GTPases	NULL
and	NULL
further	NULL
potentiate	NULL
the	NULL
basal	NULL
TCR	NULL
signals	NULL
resulting	NULL
in	NULL
IL-2	NULL
gene	NULL
activation	NULL
.	NULL

Future	NULL
mutagenesis	NULL
study	NULL
of	NULL
p95¢	NULL
``	NULL
``	NULL
and	NULL
identification	NULL
of	NULL
its	NULL
interacting	NULL
proteins	NULL
may	NULL
help	NULL
us	NULL
to	NULL
resolve	NULL
these	NULL
alternatives	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
G.	NULL
Crabtree	NULL
for	NULL
TAg	NULL
Jurkat	NULL
cells	NULL
and	NULL
reporter	NULL
plasmids	NULL
;	NULL
D.	NULL
Cantrell	NULL
for	NULL
plasmids	NULL
pEF-BOS	NULL
,	NULL
N17ras	NULL
,	NULL
and	NULL
DN-Raf	NULL
;	NULL
P.	NULL
Dazin	NULL
for	NULL
flow	NULL
cytometry	NULL
analysis	NULL
;	NULL
N.	NULL
Van	NULL
Oers	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manu-script	NULL
;	NULL
and	NULL
B.	NULL
Irving	NULL
for	NULL
helpful	NULL
discussions	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
grant	NULL
GM	NULL
44493	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
A.W	NULL
.	NULL
)	NULL

and	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Medical	NULL
Research	NULL
Council	NULL
of	NULL
Canada	NULL
(	NULL
S.K	NULL
.	NULL
)	NULL

and	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
of	NULL
Canada	NULL
(	NULL
S.K	NULL
.	NULL
)	NULL

.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Adams	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
H.	NULL
Houston	NULL
,	NULL
J.	NULL
Allen	NULL
,	NULL
T.	NULL
Lints	NULL
,	NULL
and	NULL
R.	NULL
Harvey	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
hematopoictically	NULL
expressed	NULL
vay	NULL
proto-oncogene	NULL
shares	NULL
homology	NULL
with	NULL
the	NULL
Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16.	NULL
dbl	NULL
GDP-GTP	NULL
exchange	NULL
factor	NULL
,	NULL
the	NULL
ber	NULL
gene	NULL
and	NULL
a	NULL
yeast	NULL
gene	NULL
(	NULL
CDC24	NULL
)	NULL
involved	NULL
in	NULL
cytoskeletal	NULL
organization	NULL
.	NULL

Oncogene	NULL
7:611-618.	NULL
.	NULL

Boguski	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
F.	NULL
McCormick	NULL
.	NULL

1993	NULL
.	NULL

Proteins	NULL
regulating	NULL
Ras	NULL
and	NULL
its	NULL
relatives	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
366:643-654.	NULL
.	NULL

Boguski	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
A.	NULL
Bairoch	NULL
,	NULL
T.	NULL
K.	NULL
Attwood	NULL
,	NULL
and	NULL
G.	NULL
S.	NULL
Michaels	NULL
.	NULL

1992	NULL
.	NULL

Proto-	NULL
vay	NULL
and	NULL
gene	NULL
expression	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
358:113	NULL
.	NULL

(	NULL
Letter	NULL
;	NULL
comment	NULL
.	NULL
)	NULL

.	NULL

Bram	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1994	NULL
.	NULL

Calcium	NULL
signalling	NULL
in	NULL
T	NULL
cell	NULL
stimulated	NULL
by	NULL
a	NULL
cyclophilin	NULL
B-binding	NULL
protein	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
371:355-358.	NULL
.	NULL

Bustelo	NULL
,	NULL
X.	NULL
R.	NULL
,	NULL
and	NULL
M.	NULL
Barbacid	NULL
.	NULL

1992	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
vay	NULL
proto-oncogene	NULL
product	NULL
in	NULL
activated	NULL
B	NULL
cells	NULL
.	NULL

Science	NULL
256:1196-1199.	NULL
.	NULL

Bustelo	NULL
,	NULL
X.	NULL
R.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
,	NULL
and	NULL
M.	NULL
Barbacid	NULL
.	NULL

1992	NULL
.	NULL

Product	NULL
of	NULL
vay	NULL
proto-oncogene	NULL
defines	NULL
a	NULL
new	NULL
class	NULL
of	NULL
tyrosine	NULL
protein	NULL
kinase	NULL
substrates	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
356:68-71.	NULL
.	NULL

Bustelo	NULL
,	NULL
X.	NULL
R.	NULL
,	NULL
K.	NULL
Suen	NULL
,	NULL
K.	NULL
Leftheris	NULL
,	NULL
C.	NULL
A.	NULL
Meyers	NULL
,	NULL
and	NULL
M.	NULL
Barbacid	NULL
.	NULL

1994	NULL
.	NULL

Vav	NULL
cooperates	NULL
with	NULL
Ras	NULL
to	NULL
transform	NULL
rodent	NULL
fibroblasts	NULL
but	NULL
is	NULL
not	NULL
a	NULL
Ras	NULL
GDP/GTP	NULL
exchange	NULL
factor	NULL
.	NULL

Oncogene	NULL
9:2405-2413.	NULL
.	NULL

Bustelo	NULL
,	NULL
X.	NULL
R.	NULL
,	NULL
K.	NULL
Suen	NULL
,	NULL
W.	NULL
M.	NULL
Michael	NULL
,	NULL
G.	NULL
Dreyfuss	NULL
,	NULL
and	NULL
M.	NULL
Barbacid	NULL
.	NULL

1995	NULL
.	NULL

Association	NULL
of	NULL
the	NULL
vay	NULL
proto-oncogene	NULL
product	NULL
with	NULL
poly	NULL
(	NULL
rC	NULL
)	NULL
-specific	NULL
RNA-binding	NULL
proteins	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:1324-1332.	NULL
.	NULL

Chan	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
M.	NULL
Iwashima	NULL
,	NULL
C.	NULL
W.	NULL
Turck	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1992	NULL
.	NULL

ZAP-70	NULL
:	NULL
a	NULL
7OkD	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
that	NULL
associates	NULL
with	NULL
the	NULL
TCR	NULL
{	NULL
chain	NULL
.	NULL

Cell	NULL
71:649-662	NULL
.	NULL

Clipstone	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1992	NULL
.	NULL

Identification	NULL
of	NULL
calcineurin	NULL
as	NULL
a	NULL
key	NULL
signalling	NULL
enzyme	NULL
in	NULL
T-lymphocyte	NULL
activation	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
357:695-697	NULL
.	NULL

Coppola	NULL
,	NULL
J.	NULL
,	NULL
S.	NULL
Bryant	NULL
,	NULL
T.	NULL
Koda	NULL
,	NULL
D.	NULL
Conway	NULL
,	NULL
and	NULL
M.	NULL
Barbacid	NULL
.	NULL

1991	NULL
.	NULL

Mechanism	NULL
of	NULL
activation	NULL
of	NULL
the	NULL
vay	NULL
proto-oncogene	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

2:95-105	NULL
.	NULL

Desai	NULL
,	NULL
D.	NULL
,	NULL
M.	NULL
E.	NULL
Newton	NULL
,	NULL
T.	NULL
Kadlecek	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1990	NULL
.	NULL

Stimulation	NULL
of	NULL
the	NULL
phosphatidylinositol	NULL
pathway	NULL
can	NULL
induce	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
348:66-69	NULL
.	NULL

Downward	NULL
,	NULL
J.	NULL
,	NULL
J.	NULL
D.	NULL
Graves	NULL
,	NULL
P.	NULL
H.	NULL
Warne	NULL
,	NULL
S.	NULL
Rayter	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Cantrell	NULL
.	NULL

1990	NULL
.	NULL

Stimulation	NULL
of	NULL
p21	NULL
``	NULL
``	NULL
``	NULL
upon	NULL
T-cell	NULL
activation	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
346:719-723	NULL
.	NULL

Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
J.-P.	NULL
Shaw	NULL
,	NULL
M.	NULL
R.	NULL
Bush	NULL
,	NULL
R.	NULL
E.	NULL
Replogle	NULL
,	NULL
R.	NULL
Gelagaje	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1988	NULL
.	NULL

Characterization	NULL
of	NULL
antigen	NULL
receptor	NULL
response	NULL
elements	NULL
within	NULL
the	NULL
interleukin-2	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:1715-1724	NULL
.	NULL

Emmel	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
C.	NULL
L.	NULL
Verweij	NULL
,	NULL
D.	NULL
Durand	NULL
,	NULL
K.	NULL
M.	NULL
Higgins	NULL
,	NULL
E.	NULL
Lacy	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1989	NULL
.	NULL

Cyclosporin	NULL
A	NULL
specifically	NULL
inhibits	NULL
function	NULL
of	NULL
nuclear	NULL
proteins	NULL
involved	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Science	NULL
246:1617-1619	NULL
.	NULL

Evens	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
O.	NULL
M.	NULL
Howard	NULL
,	NULL
R.	NULL
Erwin	NULL
,	NULL
and	NULL
W.	NULL
L.	NULL
Farrar	NULL
.	NULL

1993	NULL
.	NULL

Interleukin-2	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
vay	NULL
proto-oncogene	NULL
product	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
:	NULL
lack	NULL
of	NULL
requirement	NULL
for	NULL
the	NULL
tyrosine	NULL
kinase	NULL
Ick	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

294:339-342	NULL
.	NULL

16a.Fischer	NULL
,	NULL
K.-D.	NULL
,	NULL
A.	NULL
Zmuidzinas	NULL
,	NULL
S.	NULL
Gardner	NULL
,	NULL
M.	NULL
Barbacid	NULL
,	NULL
A.	NULL
Bernstein	NULL
,	NULL
and	NULL
17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

C.	NULL
Guidos	NULL
.	NULL

1995	NULL
.	NULL

Defective	NULL
T-cell	NULL
receptor	NULL
signalling	NULL
and	NULL
positive	NULL
selection	NULL
of	NULL
Vayv-deficient	NULL
CD4TCD8*	NULL
thymocytes	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
374:474-477	NULL
.	NULL

Fruman	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
C.	NULL
B.	NULL
Klee	NULL
,	NULL
B.	NULL
E.	NULL
Bierer	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Burakoff	NULL
.	NULL

1992	NULL
.	NULL

Calcineurin	NULL
phosphatase	NULL
activity	NULL
in	NULL
T	NULL
lymphocytes	NULL
is	NULL
inhibited	NULL
by	NULL
FK	NULL
506	NULL
and	NULL
cyclosporin	NULL
A.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:3686-3690	NULL
.	NULL

Galland	NULL
,	NULL
F.	NULL
,	NULL
S.	NULL
Katzayv	NULL
,	NULL
and	NULL
D.	NULL
Birnbaum	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
products	NULL
of	NULL
the	NULL
mef-2	NULL
and	NULL
vay	NULL
proto-oncogenes	NULL
and	NULL
of	NULL
the	NULL
yeast	NULL
gene	NULL
cedc-24	NULL
share	NULL
sequence	NULL
sim-ilarities	NULL
.	NULL

Oncogene	NULL
7:585-587	NULL
.	NULL

Goldsmith	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
P.	NULL
E.	NULL
Dazin	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1988	NULL
.	NULL

At	NULL
least	NULL
two	NULL
non-antigen-binding	NULL
molecules	NULL
are	NULL
required	NULL
for	NULL
signal	NULL
transduction	NULL
by	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:8613-8617	NULL
.	NULL

Goldsmith	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
D.	NULL
M.	NULL
Desai	NULL
,	NULL
T.	NULL
Schultz	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1989	NULL
.	NULL

Function	NULL
of	NULL
a	NULL
heterologous	NULL
muscarinic	NULL
receptor	NULL
in	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
signal	NULL
transduction	NULL
mutants	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264:17190-17197	NULL
.	NULL

Goldsmith	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1987	NULL
.	NULL

Isolation	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
T-lymphocyte	NULL
somatic	NULL
mutant	NULL
with	NULL
altered	NULL
signal	NULL
transduction	NULL
by	NULL
the	NULL
antigen	NULL
receptor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:6879-6883	NULL
.	NULL

Graber	NULL
,	NULL
M.	NULL
,	NULL
L.	NULL
K.	NULL
Bockenstedt	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1991	NULL
.	NULL

Signalling	NULL
via	NULL
the	NULL
inositol	NULL
phospholipid	NULL
pathway	NULL
by	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
is	NULL
limited	NULL
by	NULL
receptor	NULL
number	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:2935-2943	NULL
.	NULL

Gulbins	NULL
,	NULL
E.	NULL
,	NULL
K.	NULL
M.	NULL
Coggeshall	NULL
,	NULL
G.	NULL
Baier	NULL
,	NULL
S.	NULL
Katzay	NULL
,	NULL
P.	NULL
Burn	NULL
,	NULL
and	NULL
A.	NULL
Altman	NULL
.	NULL

1993	NULL
.	NULL

Tyrosine	NULL
kinase-stimulated	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
activity	NULL
of	NULL
vay	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Science	NULL
260:822-825	NULL
.	NULL

Gulbins	NULL
,	NULL
E.	NULL
,	NULL
K.	NULL
M.	NULL
Coggeshall	NULL
,	NULL
G.	NULL
Baier	NULL
,	NULL
D.	NULL
Telford	NULL
,	NULL
C.	NULL
Langlet	NULL
,	NULL
G.	NULL
Baier-Bitterlich	NULL
,	NULL
N.	NULL
Bonnefoy-Berard	NULL
,	NULL
P.	NULL
Burn	NULL
,	NULL
A.	NULL
Wittinghofer	NULL
,	NULL
and	NULL
A.	NULL
Altman	NULL
.	NULL

1994	NULL
.	NULL

Direct	NULL
stimulation	NULL
of	NULL
vay	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
activity	NULL
for	NULL
Ras	NULL
by	NULL
phorbol	NULL
esters	NULL
and	NULL
diglycerides	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:4749-4758.	NULL
.	NULL

Gulbins	NULL
,	NULL
E.	NULL
,	NULL
K.	NULL
M.	NULL
Coggeshall	NULL
,	NULL
C.	NULL
Langlet	NULL
,	NULL
G.	NULL
Baier	NULL
,	NULL
N.	NULL
Bonnefoy-Berard	NULL
,	NULL
P.	NULL
Burn	NULL
,	NULL
A.	NULL
Wittinghofer	NULL
,	NULL
S.	NULL
Katzav	NULL
,	NULL
and	NULL
A.	NULL
Altman	NULL
.	NULL

1994	NULL
.	NULL

Activation	NULL
of	NULL
Ras	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
intact	NULL
fibroblasts	NULL
by	NULL
the	NULL
Vav	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
protein	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:906-913	NULL
.	NULL

Gulbins	NULL
,	NULL
E.	NULL
,	NULL
C.	NULL
Langlet	NULL
,	NULL
G.	NULL
Baier	NULL
,	NULL
N.	NULL
Bonnefoy-Berard	NULL
,	NULL
E.	NULL
Herbert	NULL
,	NULL
A.	NULL
Alt-man	NULL
,	NULL
and	NULL
K.	NULL
M.	NULL
Coggeshall	NULL
.	NULL

1994	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
vay	NULL
GTP/GDP	NULL
exchange	NULL
activity	NULL
in	NULL
antigen	NULL
receptor-triggered	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

152:2123-2129	NULL
.	NULL

Gupta	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
Weiss	NULL
,	NULL
G.	NULL
Kumar	NULL
,	NULL
S.	NULL
Wang	NULL
,	NULL
and	NULL
A.	NULL
Nel	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
utilizes	NULL
LCK	NULL
,	NULL
RAF-1	NULL
and	NULL
MEK-1	NULL
for	NULL
activating	NULL
MAP	NULL
kinase	NULL
:	NULL
evidence	NULL
for	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
second	NULL
PKC-dependent	NULL
pathway	NULL
in	NULL
an	NULL
LCK-negative	NULL
Jurkat	NULL
cell	NULL
mutant	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:17349-17357	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53.	NULL
p95	NULL
``	NULL
IN	NULL
TCR	NULL
SIGNALING	NULL
4345	NULL
Hart	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
A.	NULL
Eva	NULL
,	NULL
D.	NULL
Zangrilli	NULL
,	NULL
S.	NULL
A.	NULL
Aaronson	NULL
,	NULL
T.	NULL
Evans	NULL
,	NULL
R.	NULL
A.	NULL
Cerione	NULL
,	NULL
and	NULL
Y.	NULL
Zheng	NULL
.	NULL

1994	NULL
.	NULL

Cellular	NULL
transformation	NULL
and	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
activity	NULL
are	NULL
catalyzed	NULL
by	NULL
a	NULL
common	NULL
domain	NULL
on	NULL
the	NULL
db/	NULL
oncogene	NULL
product	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:62-65	NULL
.	NULL

Hobert	NULL
,	NULL
O.	NULL
,	NULL
B.	NULL
Jallal	NULL
,	NULL
J.	NULL
Schlessinger	NULL
,	NULL
and	NULL
A.	NULL
Ullrich	NULL
.	NULL

1994	NULL
.	NULL

Novel	NULL
signaling	NULL
pathway	NULL
suggested	NULL
by	NULL
SH3	NULL
domain-mediated	NULL
p9Svav/heterogencous	NULL
ribonu-cleoprotein	NULL
K	NULL
interaction	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:20225-20228	NULL
.	NULL

Irving	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
{	NULL
chain	NULL
is	NULL
sufficient	NULL
to	NULL
couple	NULL
to	NULL
receptor-associated	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

Cell	NULL
64:891-901	NULL
.	NULL

Iwashima	NULL
,	NULL
M.	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Irving	NULL
,	NULL
N.	NULL
S.	NULL
C.	NULL
van	NULL
Oers	NULL
,	NULL
A.	NULL
C.	NULL
Chan	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1994	NULL
.	NULL

Sequential	NULL
interactions	NULL
of	NULL
the	NULL
TCR	NULL
with	NULL
two	NULL
distinct	NULL
cytoplasmic	NULL
tyrosine	NULL
kinases	NULL
.	NULL

Science	NULL
263:1136-1139	NULL
.	NULL

Izquierdo	NULL
,	NULL
M.	NULL
,	NULL
J	NULL
.	NULL

Downward	NULL
,	NULL
J.	NULL
D.	NULL
Graves	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Cantrell	NULL
.	NULL

1992	NULL
.	NULL

Role	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
in	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
regulation	NULL
of	NULL
p21	NULL
``	NULL
``	NULL
``	NULL
:	NULL
evidence	NULL
that	NULL
two	NULL
p21	NULL
``	NULL
regulatory	NULL
pathways	NULL
coexist	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:3305-3312	NULL
.	NULL

June	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
M.	NULL
C.	NULL
Fletcher	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
,	NULL
G.	NULL
L.	NULL
Schieven	NULL
,	NULL
J.	NULL
N.	NULL
Siegel	NULL
,	NULL
A.	NULL
F.	NULL
Phillips	NULL
,	NULL
and	NULL
L.	NULL
E.	NULL
Samelson	NULL
.	NULL

1990	NULL
.	NULL

Inhibition	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
prevents	NULL
T	NULL
cell	NULL
receptor-mediated	NULL
signal	NULL
transduction	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:7722-7726	NULL
.	NULL

Katzayv	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
L.	NULL
Cleveland	NULL
,	NULL
H.	NULL
E.	NULL
Heslop	NULL
,	NULL
and	NULL
D.	NULL
Pulido	NULL
.	NULL

1991	NULL
.	NULL

Loss	NULL
of	NULL
the	NULL
amino-terminal	NULL
helix-loop-helix	NULL
domain	NULL
of	NULL
the	NULL
vay	NULL
proto-oncogene	NULL
activates	NULL
its	NULL
transforming	NULL
potential	NULL
.	NULL

Molec	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:1912-1920	NULL
.	NULL

Katzav	NULL
,	NULL
S.	NULL
,	NULL
D.	NULL
Martin-Zanca	NULL
,	NULL
and	NULL
M.	NULL
Barbacid	NULL
.	NULL

1989.	NULL
vay	NULL
,	NULL
a	NULL
novel	NULL
human	NULL
oncogene	NULL
derived	NULL
from	NULL
a	NULL
locus	NULL
ubiquitously	NULL
expressed	NULL
in	NULL
hematopoictic	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:2283-2290	NULL
.	NULL

Katzav	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Sutherland	NULL
,	NULL
G.	NULL
Packham	NULL
,	NULL
T.	NULL
Yi	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
ZAP-70	NULL
can	NULL
associate	NULL
with	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
proto-vay	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:32579-32585	NULL
.	NULL

Kazanietz	NULL
,	NULL
M.	NULL
,	NULL
X.	NULL
R.	NULL
Bustelo	NULL
,	NULL
M.	NULL
Barbacid	NULL
,	NULL
W.	NULL
Kolch	NULL
,	NULL
H.	NULL
Mischak	NULL
,	NULL
G.	NULL
Wong	NULL
,	NULL
G.	NULL
R.	NULL
Pettit	NULL
,	NULL
J.	NULL
D.	NULL
Bruns	NULL
,	NULL
and	NULL
P.	NULL
M.	NULL
Blumberg	NULL
.	NULL

1994	NULL
.	NULL

Zinc	NULL
finger	NULL
domains	NULL
and	NULL
phorbol	NULL
ester	NULL
pharmacophore	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:11590-11594	NULL
.	NULL

Khosravi-Far	NULL
,	NULL
R.	NULL
,	NULL
M.	NULL
Chrzanowska-Wodnicka	NULL
,	NULL
P.	NULL
A.	NULL
Solski	NULL
,	NULL
A.	NULL
Eva	NULL
,	NULL
K.	NULL
Burr-idge	NULL
,	NULL
and	NULL
C.	NULL
J	NULL
.	NULL

Der	NULL
.	NULL

1994	NULL
.	NULL

Dbl	NULL
and	NULL
Vav	NULL
mediate	NULL
transformation	NULL
via	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
pathways	NULL
that	NULL
are	NULL
distinct	NULL
from	NULL
those	NULL
activated	NULL
by	NULL
oncogenic	NULL
Ras	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:6848-6857	NULL
.	NULL

Koch	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
D.	NULL
Anderson	NULL
,	NULL
M.	NULL
F.	NULL
Moran	NULL
,	NULL
C.	NULL
Ellis	NULL
,	NULL
and	NULL
T.	NULL
Pawson	NULL
.	NULL

1991	NULL
.	NULL

SH2	NULL
and	NULL
SH3	NULL
domains	NULL
:	NULL
elements	NULL
that	NULL
control	NULL
interactions	NULL
of	NULL
cytoplasmic	NULL
signaling	NULL
proteins	NULL
.	NULL

Science	NULL
252:668-674	NULL
.	NULL

Koretzky	NULL
,	NULL
G.	NULL
,	NULL
J.	NULL
Picus	NULL
,	NULL
T.	NULL
Schultz	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1991	NULL
.	NULL

Tyrosine	NULL
phosphatase	NULL
CD45	NULL
is	NULL
required	NULL
for	NULL
both	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
and	NULL
CD2	NULL
mediated	NULL
activation	NULL
of	NULL
a	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
and	NULL
interleukin	NULL
2	NULL
production	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:2037-2041	NULL
.	NULL

Koretzky	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
J.	NULL
Picus	NULL
,	NULL
M.	NULL
L.	NULL
Thomas	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1990	NULL
.	NULL

Tyrosine	NULL
phosphatase	NULL
CD45	NULL
is	NULL
essential	NULL
for	NULL
coupling	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
to	NULL
the	NULL
phosphatidylinositol	NULL
pathway	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
346:66-68	NULL
.	NULL

Margolis	NULL
,	NULL
B.	NULL
,	NULL
P.	NULL
Hu	NULL
,	NULL
S.	NULL
Katzayv	NULL
,	NULL
J.	NULL
M.	NULL
Oliver	NULL
,	NULL
A.	NULL
Ullrich	NULL
,	NULL
A.	NULL
Weiss	NULL
,	NULL
and	NULL
J.	NULL
Schlessinger	NULL
.	NULL

1992	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
vev	NULL
:	NULL
a	NULL
proto-oncogene	NULL
combining	NULL
SH2	NULL
and	NULL
SH3	NULL
domains	NULL
with	NULL
motifs	NULL
found	NULL
in	NULL
transcriptional	NULL
factors	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
356:71-74	NULL
.	NULL

Mizushima	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
S.	NULL
Nagata	NULL
.	NULL

1990.	NULL
pEF-BOS	NULL
,	NULL
a	NULL
powerful	NULL
mammalian	NULL
expression	NULL
vector	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18:5322	NULL
.	NULL

Musacchio	NULL
,	NULL
A.	NULL
,	NULL
T.	NULL
Gibson	NULL
,	NULL
P.	NULL
Rice	NULL
,	NULL
J.	NULL
Thompson	NULL
,	NULL
and	NULL
M.	NULL
Saraste	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
PH	NULL
domain	NULL
:	NULL
a	NULL
common	NULL
piece	NULL
in	NULL
the	NULL
structural	NULL
patchwork	NULL
of	NULL
signalling	NULL
proteins	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

18:343-348	NULL
.	NULL

Nishibe	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
I.	NULL
Wahl	NULL
,	NULL
S.	NULL
M.	NULL
Hernandez-Sotomayor	NULL
,	NULL
N.	NULL
K.	NULL
Tonk	NULL
,	NULL
S.	NULL
G.	NULL
Rhee	NULL
,	NULL
and	NULL
G.	NULL
Carpenter	NULL
.	NULL

1990	NULL
.	NULL

Increase	NULL
of	NULL
the	NULL
catalytic	NULL
activity	NULL
of	NULL
phospholipase	NULL
C-y1	NULL
by	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

Science	NULL
250:1253-1256	NULL
.	NULL

Ohashi	NULL
,	NULL
P.	NULL
,	NULL
T.	NULL
Mak	NULL
,	NULL
P.	NULL
Van	NULL
den	NULL
Elsen	NULL
,	NULL
Y.	NULL
Yanagi	NULL
,	NULL
Y.	NULL
Yasunobu	NULL
,	NULL
A.	NULL
Calman	NULL
,	NULL
C.	NULL
Terhorst	NULL
,	NULL
J.	NULL
Stobo	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1985	NULL
.	NULL

Reconstitution	NULL
of	NULL
an	NULL
active	NULL
surface	NULL
T3/T-cell	NULL
antigen	NULL
receptor	NULL
by	NULL
DNA	NULL
transfer	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
316:606-609	NULL
.	NULL

O'Keefe	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
J.	NULL
Tamura	NULL
,	NULL
R.	NULL
L.	NULL
Kincaid	NULL
,	NULL
M.	NULL
J.	NULL
Tocci	NULL
,	NULL
and	NULL
E.	NULL
A.	NULL
O'Neil	NULL
.	NULL

1992	NULL
.	NULL

FK-506-	NULL
and	NULL
CsA-sensitive	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
by	NULL
calcineurin	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
357:692-694	NULL
.	NULL

Owaki	NULL
,	NULL
H.	NULL
,	NULL
R.	NULL
Varma	NULL
,	NULL
B.	NULL
Gills	NULL
,	NULL
J.	NULL
T.	NULL
Bruder	NULL
,	NULL
U.	NULL
R.	NULL
Rapp	NULL
,	NULL
L.	NULL
S.	NULL
Davis	NULL
,	NULL
and	NULL
T.	NULL
D.	NULL
Geppert	NULL
.	NULL

1993	NULL
.	NULL

Raf-1	NULL
is	NULL
required	NULL
for	NULL
T	NULL
cell	NULL
IL-2	NULL
production	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:4367-4373	NULL
.	NULL

Price	NULL
,	NULL
L.	NULL
S.	NULL
,	NULL
J.	NULL
C.	NULL
Norman	NULL
,	NULL
A.	NULL
J.	NULL
Ridley	NULL
,	NULL
and	NULL
A.	NULL
Koffer	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
small	NULL
GTPases	NULL
Rac	NULL
and	NULL
Rho	NULL
as	NULL
regulators	NULL
of	NULL
secretion	NULL
in	NULL
mast	NULL
cells	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

5:68-73	NULL
.	NULL

Ravichandran	NULL
,	NULL
K.	NULL
,	NULL
U.	NULL
Lorenz	NULL
,	NULL
S.	NULL
E.	NULL
Shoelson	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Burakoff	NULL
.	NULL

1995	NULL
.	NULL

Interaction	NULL
of	NULL
She	NULL
with	NULL
Grb2	NULL
regulates	NULL
association	NULL
of	NULL
Grb2	NULL
with	NULL
mSOS	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:593-600	NULL
.	NULL

Rayter	NULL
,	NULL
S.	NULL
I.	NULL
,	NULL
M.	NULL
Woodrow	NULL
,	NULL
S.	NULL
C.	NULL
Lucas	NULL
,	NULL
D.	NULL
A.	NULL
Cantrell	NULL
,	NULL
and	NULL
J	NULL
.	NULL

Downward	NULL
.	NULL

1992.	NULL
p21'*	NULL
``	NULL
``	NULL
mediates	NULL
control	NULL
of	NULL
IL-2	NULL
gene	NULL
promoter	NULL
function	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:4549-4556	NULL
.	NULL

Reibel	NULL
,	NULL
L.	NULL
,	NULL
O.	NULL
Dorseuil	NULL
,	NULL
R.	NULL
Stancou	NULL
,	NULL
J.	NULL
Bertoglio	NULL
,	NULL
and	NULL
G.	NULL
Gacon	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
hematopoietic	NULL
specific	NULL
gene	NULL
encoding	NULL
a	NULL
small	NULL
GTP	NULL
binding	NULL
protein	NULL
is	NULL
overexpressed	NULL
during	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Comm	NULL
.	NULL

175:451-458	NULL
.	NULL

Ridley	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
A	NULL
.	NULL

Hall	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
small	NULL
GTP-binding	NULL
protein	NULL
tho	NULL
regulates	NULL
4346	NULL
54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

WU	NULL
ET	NULL
AL	NULL
.	NULL

the	NULL
assembly	NULL
of	NULL
focal	NULL
adhesions	NULL
and	NULL
actin	NULL
stress	NULL
fibers	NULL
in	NULL
response	NULL
to	NULL
growth	NULL
factors	NULL
.	NULL

Cell	NULL
70:389-399	NULL
.	NULL

Ridley	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
H.	NULL
F.	NULL
Paterson	NULL
,	NULL
C.	NULL
L.	NULL
Johnston	NULL
,	NULL
D.	NULL
Diekmann	NULL
,	NULL
and	NULL
A	NULL
.	NULL

Hall	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
small	NULL
GTP-binding	NULL
protein	NULL
rac	NULL
regulates	NULL
growth	NULL
factor-induced	NULL
membrane	NULL
ruffling	NULL
.	NULL

Cell	NULL
70:401-410	NULL
.	NULL

Romeo	NULL
,	NULL
C.	NULL
,	NULL
M.	NULL
Amiot	NULL
,	NULL
and	NULL
B	NULL
.	NULL

Seed	NULL
.	NULL

1992	NULL
.	NULL

Sequence	NULL
requirements	NULL
for	NULL
induction	NULL
of	NULL
cytolysis	NULL
by	NULL
the	NULL
T	NULL
cell	NULL
antigen/Fc	NULL
receptor	NULL
{	NULL
chain	NULL
.	NULL

Cell	NULL
68:889-897	NULL
.	NULL

Schlessinger	NULL
,	NULL
J	NULL
.	NULL

1993	NULL
.	NULL

How	NULL
receptor	NULL
tyrosine	NULL
kinases	NULL
activate	NULL
Ras	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

18:273-275	NULL
.	NULL

Sich	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Batzer	NULL
,	NULL
J.	NULL
Schlessinger	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1994	NULL
.	NULL

GRB2	NULL
and	NULL
phospholipase	NULL
C-y1	NULL
associate	NULL
with	NULL
a	NULL
36-	NULL
to	NULL
38-kilodalton	NULL
phosphotyrosine	NULL
protein	NULL
after	NULL
T-cell	NULL
receptor	NULL
stimulation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:4435-4442	NULL
.	NULL

Sich	NULL
,	NULL
M.	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Bolen	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1993	NULL
.	NULL

CD45	NULL
specifically	NULL
modulates	NULL
binding	NULL
of	NULL
Lek	NULL
to	NULL
a	NULL
phosphopeptide	NULL
encompassing	NULL
the	NULL
negative	NULL
regulatory	NULL
tyrosine	NULL
of	NULL
Lek	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:315-322	NULL
.	NULL

Straus	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1992	NULL
.	NULL

Genetic	NULL
evidence	NULL
for	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
Leck	NULL
tyrosine	NULL
kinase	NULL
in	NULL
signal	NULL
transduction	NULL
through	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
.	NULL

Cell	NULL
70:585-593	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Tarakbovsky	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Turner	NULL
,	NULL
S.	NULL
Schaal	NULL
,	NULL
P.	NULL
J.	NULL
Mee	NULL
,	NULL
L.	NULL
P.	NULL
Duddy	NULL
,	NULL
K.	NULL
Rajewsky	NULL
,	NULL
and	NULL
V.	NULL
L.	NULL
J.	NULL
Tybulewicz	NULL
.	NULL

1995	NULL
.	NULL

Defective	NULL
antigen	NULL
receptor-mediated	NULL
proliferation	NULL
of	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Vav	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
374:467-470	NULL
.	NULL

Weiss	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Littman	NULL
.	NULL

1994	NULL
.	NULL

Signal	NULL
transduction	NULL
by	NULL
lymphocyte	NULL
antigen	NULL
receptors	NULL
.	NULL

Cell	NULL
76:263-274	NULL
.	NULL

Weiss	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Stobo	NULL
.	NULL

1984	NULL
.	NULL

Requirement	NULL
for	NULL
the	NULL
coexpression	NULL
of	NULL
T3	NULL
and	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
on	NULL
a	NULL
malignant	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

160:1284-1299	NULL
.	NULL

Woodrow	NULL
,	NULL
M.	NULL
,	NULL
N.	NULL
A.	NULL
Clipstone	NULL
,	NULL
and	NULL
D.	NULL
Cantrell	NULL
.	NULL

1993.	NULL
p21ras	NULL
and	NULL
calcineurin	NULL
synergize	NULL
to	NULL
regulate	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1517-1522	NULL
.	NULL

Zhang	NULL
,	NULL
R.	NULL
,	NULL
F.	NULL
W.	NULL
Alt	NULL
,	NULL
L.	NULL
Davidson	NULL
,	NULL
S.	NULL
H.	NULL
Orkin	NULL
,	NULL
and	NULL
W.	NULL
Swat	NULL
.	NULL

1995	NULL
.	NULL

Defective	NULL
signaling	NULL
through	NULL
the	NULL
T	NULL
and	NULL
B	NULL
cell	NULL
antigenreceptors	NULL
in	NULL
lymphoid	NULL
cells	NULL
lacking	NULL
the	NULL
vay	NULL
proto-oncogene	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
374:470-473	NULL
.	NULL

Zmuidzinas	NULL
,	NULL
A.	NULL
,	NULL
K.	NULL
Fischer	NULL
,	NULL
S.	NULL
A.	NULL
Lira	NULL
,	NULL
L.	NULL
Forrester	NULL
,	NULL
S.	NULL
Bryant	NULL
,	NULL
A.	NULL
Bernstein	NULL
,	NULL
and	NULL
M.	NULL
Barbacid	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
vay	NULL
proto-oncogene	NULL
is	NULL
required	NULL
carly	NULL
in	NULL
embry-ogenesis	NULL
but	NULL
not	NULL
for	NULL
hematopoietic	NULL
development	NULL
in	NULL
vifro	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:1-11	NULL
.	NULL

